Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$LAHO ADIMARKET TOP COMPETITORS
Johns Hopkins
The most successful stem cell therapy—bone marrow transplant—has been around for more than 40 years. Johns Hopkins researchers played an integral role in establishing the methods for how bone marrow transplants are done, which you can read about in Human Stem Cells at Johns Hopkins: A Forty Year History. The latest developments in bone marrow transplants are Half-Matched Transplants, which may be helpful in treating more diseases than ever before. In The Promise of the Future, three Hopkins researchers who study blood diseases share their ideas about which technologies hold most promise for developing therapies.
https://www.hopkinsmedicine.org/stem_cell_research/cell_therapy/index.html
$LAHO
$LAHO $600 Billion bofA..Wall Street’s major investment banks.
..One of the biggest investment opportunities over the next decade will be in companies working to delay human death, a market expected to be worth at least $600 billion by 2025
Intuitive Surgical Inc (ISRG:NASDAQ) $489.42
https://www.worldstemcellsummit.com/2019/05/09/human-lifespan-could-soon-pass-100-years-thanks-to-medical-tech-says-bank-of-america/
..Magellan system is a perfect fit for GSCG and Adimarket’s ever-growing list of high-tech regenerative medicine products and equipment, made available to physicians and qualified practitioners through the Adimarket online store.
..As an industry leader, Adimarket added the Magellan Autologous Platelet Separator System to its online regenerative medicine store to allow physicians to meet the specific needs of each patient with fully customizable product volumes and platelet concentrations.
https://www.prunderground.com/global-stem-cells-group-and-adimarket-to-represent-magellan-in-latin-america-and-middle-east/00112628/
https://www.printfriendly.com/p/g/HhXTsp
For a limited time promotional shipping rates are available on most orders over $ 5000 .
https://www.adimarket.net/how-to-order/
$LAHO GSCG Magellan
$LAHO upsurge in venture capital investment..growth of 7,300%
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
..“Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth,” says the US National Institutes of Health. “In many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive
Market cap: $2.09 billion; current share price: $24.25
Market cap: $226.15 Million; current share price: $1.83
Market cap: $161.84 million; current share price: $1.47
Market cap: $267.60 million; current share price: $19.10
Market cap: $392.71 million; current share price: $11.25
Market cap: $64.63 million; current share price: $3.43
Market cap: $54.74 million; current share price: $5.78
Market cap: $11.05 million; current share price: $0.31
Market cap: $29.88 million; current share price: $2.75
Market cap: $28.40 million; current share price: $1.30
https://investingnews.com/daily/life-science-investing/genetics-investing/top-stem-cell-nasdaq/
Adimarket 119 pages Medical devices!
https://2nvdue1pi3s51uaik42s7kgz-wpengine.netdna-ssl.com/wp-content/uploads/2017/05/ADIMarket_1.pdf
$LAHO Sorry I don't have PM. Factfinders work,Cheers.
$LAHO Stem cells The Holy Grail Stansberry report!
This may sound like science fiction. But it's not...
Gene therapy and editing is a real and growing trend you will hear about much more over the next several years. More from Christian...
This is real personalized medicine,which is the "Holy Grail."
https://stansberryresearch.com/articles/the-most-expensive-tech-stock-in-the-world-today-2
Regenerative medicine..USDHHS..conservatively estimated..$500 billion by 2020
..Because of the economic potential of this industry (the worldwide market for regenerative medicine is conservatively estimated to be $500 billion..
http://singularity-2045.org/HHS-regenerative-medicine-2020-vision-archive-2014.html
Harvard Stem Cell
..Our mission is to find cures for human diseases.
https://hsci.harvard.edu/
Yale
The potential impact of stem cell research on human health is enormous.
https://medicine.yale.edu/stemcell/people/research/therapy.aspx
https://medicine.yale.edu/news/medicineatyale/a-shangrila-for-stem-cell-research-at-yale.aspx
OXFORD
a revolution in biology has meant that effective regenerative medicine, using stem cells to replace and repair damaged tissue is now on the horizon.
https://www.stemcells.ox.ac.uk/home
FDA says it’s unable to use the incomplete adverse event reporting data to quantify overall deaths that result from therapeutic drug use.
https://www.google.com/amp/s/health.usnews.com/health-news/patient-advice/articles/2016-09-27/the-danger-in-taking-prescribed-medications%3fcontext=amp
Who to trust?? Yale Harvard,Oxford or FDA AHHAHAA
$LAHO FDA COLLECTS BILLIONS NOT ACCOUNTABLE FOR WHO DIES FROM BIG PHARM, SIMPLY RECALL AND INSURANCE COMPANIES SETTLE WITHOUT ADMITTING. CHOSE YOUR SIDE WAR ECONOMY
$LAHO..BofA..delay..death..market..worth at least $600 billion by 2025, according to one of Wall Street’s major investment banks.
..‘AMMORTALITY’
The “ammortality” theme, expected to be worth $504 billion by 2025, “will help to improve health spans & [lifespans] to the betterment of human vitality, enabling the world population to live freer of disease rather than forever.”
Companies that represent “ammortality” plays as described by BofA include health-care technology firms such as Intuitive Surgical and Zimmer, which worked with Apple Watch to start a clinical study for 10,000 knee and hip replacement
https://www.worldstemcellsummit.com/2019/05/09/human-lifespan-could-soon-pass-100-years-thanks-to-medical-tech-says-bank-of-america/
OXFORD
Human cells and tissues for transplantation can save lives or restore essential function
a corneal graft can restore sight in corneal blindness;
the transplantatin
https://www.who.int/transplantation/cell_tissue/en/
Adimarket, has announced an agreement with biotechnology company Alolotl Biologix
..healing for a range of conditions, including orthopedic impairments, wound care, pain management, ophthalmic, cardiovascular, cosmetic, and more.
Human allograft under FDA regulation 21 CFR Part 1271 ..Immune privileged with anti-inflammatory and anti-bacterial properties
https://www.prunderground.com/adimarket-has-announced-an-agreement-with-biotechnology-company-alolotl-biologix/00114544/
GSCG ISSCA Launch Dates.
•Santiago de Chile, Chile: September 5, 2019
•Bogota, Colombia: October 4, 2019
•Buenos Aires, Argentina: October 11, 2019
•Miami, Florida (in English): November 1, 2019
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149621212
Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/
State-Of-The-Art Equipment
We’ll set you up with the best equipment you need to process stem cells and carry out the regenerative procedures for your patients..
http://stemcellslab.net/facility-and-equipment/
$LAHO $600B market ever increasing. Cash business, even when financed GSCG collects.
$LAHO ..Regenerative Medicine RM) Industry..rapidly expanding in recent years, making it a high-value, fast-growth market..Big Pharma is also demonstrating a snowballing interest in regenerative medicine.
The Regenerative Medicine (RM) Industry includes companies that are developing:
Stem cell therapies
Cellular therapies
Gene therapies
Tissue engineering
Direct cell reprogramming
Exosome therapies
Cellular scaffolds and matrices
3D bioprinting
Biomaterials
Combination Products
And More
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
..Global Stem Cells Group (GSCG), a world leader in stem cell and regenerative medicine, announces it will represent CELLLINK 3D Bioprinting Technology in Latin America. CELLINK is the world’s first company biotech company to market bioinks for 3D bioprinting of human organs and tissue.
http://www.stemcellsgroup.com/tag/3d-bioprinnting/
3D Bioprinting Market To Reach USD 4.40 Billion
.. rise in geriatric population, technological improvements for manufacturing customized Material Types, and growth in focus on R&D investment. Also, the increase in usage of 3D printing in cosmetic surgeries is anticipated to increase the market growth during the forecast period further.
https://www.globenewswire.com/news-release/2019/05/02/1815536/0/en/3D-Bioprinting-Market-To-Reach-USD-4-40-Billion-By-2026-Reports-And-Data.html
$LAHO GSCG
$LAHO Adimarket..launch..Cellgenic stem cell protein extract hair restoration product
GSCG affiliate Adimarket announces the launch of the Cellgenic adipose-derived stem cell hair restoration application that maximizes the skin and hair follicles’ own revitalizing capabilitie
..When used by aesthetic practitioners, CADPE provides safe, cutting-edge hair thickening and hair follicle proliferation results that are CTFA-approved, take less application time than other hair restoration processes, and is backed by medical research.
http://www.stemcellsgroup.com/cadpe-stem-cell-hair-restoration-application/
Hair Transplant Market worth over $24.8 billion by 2024: Global Market Insights, Inc.
https://www.globenewswire.com/news-release/2018/08/14/1551331/0/en/Hair-Transplant-Market-worth-over-24-8-billion-by-2024-Global-Market-Insights-Inc.html
$LAHO GSCG
$LAHO GSCG Adimarket to Represent Magellan..
http://www.stemcellsgroup.com/magellan-autologous-platelet-separator/screen-shot-2017-11-28-at-2-42-03-am/
Global Stem Cells Group (GSCG), a world leader in stem cell and regenerative medicine, and its subsidiary Adimarket have been named to represent the Magellan Autologous Platelet Separator in Latin America and Middle East.
Global Stem Cells Group CEO Benito Novas says the Magellan system is a perfect fit for GSCG and Adimarket’s ever-growing list of high-tech regenerative medicine products and equipment, made available to physicians and qualified practitioners through the Adimarket online store.
..As an industry leader, Adimarket added the Magellan Autologous Platelet Separator System to its online regenerative medicine store to allow physicians to meet the specific needs of each patient with fully customizable product volumes and platelet concentrations.
https://www.prunderground.com/global-stem-cells-group-and-adimarket-to-represent-magellan-in-latin-america-and-middle-east/00112628/
$LAHO GSCG Magellan!
$LAHO BAC.. delay.. death..market..worth at least $600 billion by 2025, according to one of Wall Street’s major investment banks.
..‘AMMORTALITY’
The “ammortality” theme, expected to be worth $504 billion by 2025, “will help to improve health spans & [lifespans] to the betterment of human vitality, enabling the world population to live freer of disease rather than forever.”
Companies that represent “ammortality” plays as described by BofA include health-care technology firms such as Intuitive Surgical and Zimmer, which worked with Apple Watch to start a clinical study for 10,000 knee and hip replacement pa
https://www.worldstemcellsummit.com/2019/05/09/human-lifespan-could-soon-pass-100-years-thanks-to-medical-tech-says-bank-of-america/
Regenerative medicine will dramatically alter the U.S. healthcare industry
..Because of the economic potential of this industry (the worldwide market for regenerative medicine is conservatively estimated to be $500 billion[/u]..
http://singularity-2045.org/HHS-regenerative-medicine-2020-vision-archive-2014.html
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150224543
$LAHO GSCG is multi-company golden future given demand and future outlook of global healthcare dynamics.
In my obervation we will surpass most aformentioned recent runners.
Measure it as due!
$LAHO Medicine. The blood stem cell Holy Grail?
https://www.ncbi.nlm.nih.gov/m/pubmed/20829472/
Studies a U.S. FDA-regulated Device Product: YES
Estimated Study Start Date : May 13, 2019
Estimated Primary Completion Date : September 15, 2020
Estimated Study Completion Date : November 1, 2020
https://clinicaltrials.gov/ct2/show/NCT03752827
Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150224543
$LAHO
$LAHO The Holy Grail of Orthopedic Surgery: Mesenchymal Stem Cells-Their Current Uses and Potential
Applications.
MSCs are easily obtained and can be cultivated and expanded in vitro; thus, they represent a promising and encouraging treatment approach in orthopedic surgery.
https://www.ncbi.nlm.nih.gov/m/pubmed/28698718/
Adimarket, has announced an agreement with biotechnology company Alolotl Biologix
..healing for a range of conditions, including orthopedic impairments, wound care, pain management, ophthalmic, cardiovascular, cosmetic, and more.
Human allograft under FDA regulation 21 CFR Part 1271 ..Immune privileged with anti-inflammatory and anti-bacterial properties
https://www.prunderground.com/adimarket-has-announced-an-agreement-with-biotechnology-company-alolotl-biologix/00114544/
$LAHO
$LAHO Regenerative medicine will dramatically alter the U.S. healthcare industry
http://singularity-2045.org/HHS-regenerative-medicine-2020-vision-archive-2014.html
upsurge in venture capital investment..growth of 7,300%
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
New stem cell combination could help to repair damaged hearts
1 day ago British Heart Foundation
https://medicalxpress.com/news/2019-08-stem-cell-combination-hearts.amp
Turkish stem cell center becomes beacon of hope for over thousands of patients
https://www.dailysabah.com/turkey/2019/08/02/turkish-stem-cell-center-becomes-beacon-of-hope-for-over-thousands-of-patients/amp
Discovery of a Liver 'Stem Cell' Could One Day Make Liver Transplants Redundant
BY CARLY CASSELLA JULY 31, 2019
https://www.sciencealert.com/discovery-of-a-new-liver-cell-could-make-liver-transplants-redundant-scientists-say/amp
$LAHO GSCG VALUE
$LAHO..has engaged Fruci & Associates as its auditors as it moves forward to complete its audits and reviews of its financials to bring the company back to current status.
https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1404069
ADMIMARKET BIOTECHNOLOGY BIOMEDICAL EQUIPMENT CATALOGUE
https://2nvdue1pi3s51uaik42s7kgz-wpengine.netdna-ssl.com/wp-content/uploads/2017/05/ADIMarket_1.pdf
YALE
Stem cells..jacks of all trades. alleviating..heart attacks, strokes and cancer.
..In a new study, Yale researchers succeeded in doing so, opening the door to new stem cell-inspired, cell-free treatments for the effects of a heart attack.
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
$LAHO GSCG
$LAHO..Stem Cell Center, Inc. is the world's largest collective support & advisory network of regenerative medicine clinics and and physicians.
http://stemcellcenter.net/
$LAHO GSCG
$LAHO CONSUMER REPORT..stem cells market..envisaged to gain a whole lot..
https://consumerreportsreview.com/stem-cells-market-is-likely-to-exhibit-a-strong-13-80-cagr-between-2017-and-2025/
GSCG. world's largest collective support & advisory network of regenerative medicine clinics and and physicians
http://stemcellcenter.net/
Yale
The potential impact of stem cell research on human health is enormous.
https://medicine.yale.edu/stemcell/people/research/therapy.aspx
https://medicine.yale.edu/news/medicineatyale/a-shangrila-for-stem-cell-research-at-yale.aspx
Stem Data - The First Clinical Record of Regenerative Medicine in the Cloud.
http://stemdata.org
$LAHO volume, value right here!
$LAHO Harvard.The history of stem cells and the future of medicine!
https://hsci.harvard.edu/links/history-stem-cells-and-future-medicine
Dr Cowan: I'm extremely bullish on that. That has been my entire research career—trying to see and realize the promise of what we often term "regenerative medicine"—taking cells and replacing damaged or lost cells that have resulted in disease. The first place this is happening is in macular degeneration. There are now trials for Parkinson's disease, which is going to be amazing, and two or three trials are opening up for type 1 diabetes.
https://www.medscape.com/viewarticle/862921?src=WNL_topol_1on1_MSCPEDIT&uac=&impID=1091812&faf=1
Stem Cells Are Poised to Change Health and Medicine Forever
https://www.google.com/amp/s/singularityhub.com/2017/01/17/stem-cells-are-poised-to-change-health-and-medicine-forever/amp/
Stem cells: the future of medicine
Future of Stem Cell Therapeutics
Over the last decade, the number of publications per year on stem cell-related research has increased 40x.
https://medicalxpress.com/news/2017-06-stem-cells-future-medicine.amp
$LAHO MASSIVE WAVES BACKED BY SCIENCE!
$LAHO..CONSUMER REPORT..stem cells market..envisaged to gain a whole lot of demand
..As a result, stem cells have been used in the treatment of various diseases and witnessed the discovery of several clinical applications previously unfolded. Players could look to broaden their cellular therapy portfolios to include a wide scope of diseases such as Alzheimer’s, type 1 diabetes, Parkinson’s, and spinal cord injury. This could be due to the worldwide acknowledgement of cellular therapies being the next major step in healthcare improvement.
https://consumerreportsreview.com/stem-cells-market-is-likely-to-exhibit-a-strong-13-80-cagr-between-2017-and-2025/
GSCG. world's largest collective support & advisory network of regenerative medicine clinics and and physicians
http://stemcellcenter.net/
$LAHO
$LAHO ..Excited about latest press release..
https://www.linkedin.com/company/lans-holdings-inc
$LAHO MAKING MASSIVE WAVES!
$LAHO GSCG has named Aesthetic Polyclinic in Abu Dhabi, UAE, exclusive representative for GSCG in that city.
Global Stem Cells Group and Adimarket to Represent Magellan in Latin America and Middle East.
https://www.prunderground.com/global-stem-cells-group-and-adimarket-to-represent-magellan-in-latin-america-and-middle-east/00112628/
Novas’ travel took him to Dubai, Oman and Kuwait where he met with investors and learned more about medical regulations in the region.
https://www.kuam.com/story/40113402/global-stem-cells-group-visits-middle-east-in-effort-to-expand-access-to-regenerative-medicine
$LAHO
$LAHO Linkedin excited about latest press release..
https://www.linkedin.com/company/lans-holdings-inc
How To Effectively Treat Amyotrophic Lateral Sclerosis (ALS)
Thursday, 01 August 2019 by Benito Novas
..When testing this newfound research on animals, the lifespan of the subjected animal has increased with MSC transplantation. These positive results have encouraged the administration of MSC in ALS patients
http://www.stemcellsgroup.com/category/latest-news/
$LAHO MASSIVE WAVES!
$LAHO CONSUMER REPORT..stem cells market..envisaged to gain a whole lot of demand
..As a result, stem cells have been used in the treatment of various diseases and witnessed the discovery of several clinical applications previously unfolded. Players could look to broaden their cellular therapy portfolios to include a wide scope of diseases such as Alzheimer’s, type 1 diabetes, Parkinson’s, and spinal cord injury. This could be due to the worldwide acknowledgement of cellular therapies being the next major step in healthcare improvement.
https://consumerreportsreview.com/stem-cells-market-is-likely-to-exhibit-a-strong-13-80-cagr-between-2017-and-2025/
The potential impact of stem cell research on human health is enormous.
https://medicine.yale.edu/stemcell/people/research/therapy.aspx
https://medicine.yale.edu/news/medicineatyale/a-shangrila-for-stem-cell-research-at-yale.aspx
Medical researchers believe that stem cell treatments have the potential to change the face of human disease and alleviate suffering.
https://www.sciencedaily.com/terms/stem_cell_treatments.htm
$LAHO
$LAHO.. world's largest collective support & advisory network of regenerative medicine clinics and and physicians
http://stemcellcenter.net/
Yale
The potential impact of stem cell research on human health is enormous.
https://medicine.yale.edu/stemcell/people/research/therapy.aspx
https://medicine.yale.edu/news/medicineatyale/a-shangrila-for-stem-cell-research-at-yale.aspx
Medical researchers believe that stem cell treatments have the potential to change the face of human disease and alleviate suffering.
https://www.sciencedaily.com/terms/stem_cell_treatments.htm
making the benefits of stem cell medicine a reality for both doctors and patients worldwide.
Through Stem Cell Training, Inc., we provide intensive, hands-on stem cell training to qualified physicians and high level medical professionals worldwide, which includes regenerative medicine fundamentals and the latest cellular medicine protocols. Through our stem cell training programs, physicians are able to provide life-changing medical solutions for patients in their office or clinical setting. Through Stem Cell Training Inc., we share the latest methods, know-how, and technological facilities with medical professionals. We offer courses, seminars, and workshops year round on stem cell therapy and treatments.
Through AdiMarket, we provide an online resource center for biomedical products and equipment needed to conduct stem cell therapies in office or clinic. AdiMarket is staffed by knowledgeable attendants to help each physician fulfill their specific product and equipment needs.
GSCG’s Stem Cell Center is a one-of-a-kind worldwide medical practice network of highly qualified, experienced physicians who provide stem cell solutions within their areas of practice. Stem Cell Center is the largest membership network of regenerative medicine clinics in the world, providing cutting edge care with the latest advancements in cellular therapies to patients worldwide. Stem Cell Center's mission is to make the promise of stem cell medicine become a reality for patients around the world.
Stem Data is a powerful Regenerative medicine Practice Management System designed to be an all-in-one, easy-to-use, intuitive, patient data management software for any healthcare environment.
And finally our Stem Cell laboratory Division offers a turn key state of the art stem cell processing center allowing our clients to conduct research and perform highly advanced stem cell procedures.
http://www.stemcellsgroup.com/our-story/
$LAHO Time to clear 12's, move up and close-green!
This is real personalized medicine, which is the "Holy Grail.
https://stansberryresearch.com/articles/the-most-expensive-tech-stock-in-the-world-today-2
Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/
Stem Data - The First Clinical Record of Regenerative Medicine in the Cloud.
http://stemdata.org
Stem cells the future of medicine.
$LAHO..36 Stem Centers, 27 Countries..USDHHS conservative estimate $500 billion
Lans Holdings, Inc.
Our Email is:-investors@lansholdings.com
investors@lans.holdings
info@lansholdings.com
bizdev@lansholdings.com
For further information, please contact:
Telephone: +1.786.786.5758 and 305-755-7451
https://www.otcmarkets.com/stock/LAHO/disclosure
..(GSCG)..binding letter..to sell 100% to Lans Holdings Inc. (OTCPink: LAHO)
https://www.stemcellsgroup.com/lans-holdings-enters-into-binding-loi-to-acquire-global-stem-cells-group/
SEC filed.. penalty of $500,000 for the party that breaches terms of the binding LOI.
Lans Holdings Successfully Completes Due Diligence of Global Stem Cells Group
https://www.otcmarkets.com/stock/LAHO/news
$24.4M Zoominfo Prior Q
https://www.zoominfo.com/c/global-stem-cells-group-inc/357592775
AdiMarket $10M
1 of 27 Facilities, Stem Cells Group Chile $5.6M!
We’re positioning Adimarket to become the largest e-commerce marketplace for all things regenerative medicine,” says Benito Novas, founder and CEO of Global Stem Cells Group.
http://www.stemcellsgroup.com/adimarket-launches-website/
..Stem Cell Center, Inc. is the world's largest collective support & advisory network of regenerative medicine clinics and and physicians
http://stemcellcenter.net/
ADMIMARKET BIOTECHNOLOGY BIOMEDICAL EQUIPMENT CATALOGUE
https://2nvdue1pi3s51uaik42s7kgz-wpengine.netdna-ssl.com/wp-content/uploads/2017/05/ADIMarket_1.pdf
Advisory board!
http://adimarket.info/advisory-board/
https://stemcellsgroup.cl/scg/
http://stemcellcenter.net/
http://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=OfficerRegisteredAgentName&directionType=Initial&searchNameOrder=NOVASBENITO%20L120000749410&aggregateId=flal-l12000074941-c51a8233-2938-4f22-b6c7-c111a2e55ddc&searchTerm=Novasanos&listNameOrder=NOVASANOS%20F120000001373
https://www.marketwatch.com/press-release/global-stem-cell-therapy-market-insight-business-evaluation-dimension-industry-grow-at-cagr-of-3652-trends-and-forecasts-2018-2023-2019-03-06
..upsurge in venture capital investment represents growth of 7,300%
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
Regenerative medicine..USDHHS..conservatively estimated..$500 billion by 2020
Regenerative medicine will dramatically alter the U.S. healthcare industry
..Because of the economic potential of this industry (the worldwide market for regenerative medicine is conservatively estimated to be $500 billion..
An example of some conditions and diseases that could be easily cured by regenerative medicine and their current cost of treatmentt include:
250,000 patients receive heart valves, at a cost of $27 billion annually
950,000 people die of heart disease or stroke, at a cost of $351 billion annually(8)
17 million patients with diabetes, at a cost of $132 billion annually
..By doing so, we can make tissue and organ failure a relic of the past by 2020.
Interagency Federal Working Group on Regenerative Medicine
Chair
Howard Zucker, MD, JD
Deputy Assistant Secretary for Health
U.S. Department of Health and Human Services
National Institutes of Health
Donna Dean, PhD
Colleen Guay-Broder, MPH
Eleni Kousvelari, PhD
Christine Kelley, PhD
John Watson, PhD
Josh Zimmerberg, PhD
Food and Drug Administration
Charles Durfor, PhD
Donald Fink, PhD
Joyce Frey, PhD
Jesse Goodman, MD
Darin Weber, PhD
Celia Witten, PhD
http://singularity-2045.org/HHS-regenerative-medicine-2020-vision-archive-2014.html
Global Stem..Market to Reach US$ 467 billion by 2024 ..Due to the increased funding from Government and Private sector and rising global awareness.
https://www.marketwatch.com/press-release/global-stem-cells-market-is-determined-to-reach-us-467-billion-by-2024-2019-03-05
The Shiller P/E is a more reasonable market valuation indicator than the P/E ratio because it eliminates fluctuation of the ratio caused by the variation of profit margins during business cycles.
Sector Healthcare: 30.50
Sector Technology: 34.40
https://www.gurufocus.com/shiller-PE.php
http://www.econ.yale.edu/~shiller/
BioTechnology
https://www.nasdaq.com/press-release/laho-global-stem-cells-group-announces-opening-of-two-new-stem-cell-centers-20190612-00503
GSCG Attorney ERIC P. GROS-DUBOIS Flawless AVVO!
https://www.avvo.com/attorneys/33135-fl-eric-grosdubois-3340017.html
Eric P. Gros-Dubois, Esq.
Founding Partner
eric@epgdlaw.com
Executive Committee and Board Member of the Coral Gables Chamber of Commerce, former President of the Rotary Club of Brickell, current President of BNI Coral Gables, past president of his home owner’s association, and supporter of many fundraisers devoted to the community. Eric also regularly teaches other lawyers for their continuing legal education, presents to The American Immigration Lawyers Association, and more.
Washington College of Law. Juris Doctor (JD)
Kogod School of Business. Masters in Business Administration (MBA)
Southern Methodist University. Bachelor of Arts (BA). Sigma Chi Fraternity
Jesuit College Preparatory School, Dallas
Bar Admissions:
State of New York
State of Maryland
District of Columbia
State of Florida
Federal District Court for the Southern District of Florida
Federal District Court for Maryland
U.S. Tax Court
CLE Lecture: “The New Tax Rules for Mergers and Acquisitions.” June, 2018
https://www.epgdlaw.com/eric-p-gros-dubois/
https://www.floridabar.org/directories/find-mbr/profile/?num=83381
Scientists Are Developing New Ways to Treat Disease With Cells, Not Drugs
https://www.cancerresearch.org/blog/december-2018/james-allison-nobel-postdoc-fellow-perspectives
GSCG conference in Japan..
..After receiving a personal invitation from President Susumu Takayangi MD, Global Stem Cells Group and its Korean biotechnology partner, N-Biotek, participated in the 23rd Congress of the International Society of Aesthetic Plastic Surgeons that took place this October in Kyoto.
The Congress brought together an expert panel for a series of lectures and discussions that hope to provide solutions and create new techniques in the coming years to be applied in plastic and reconstructive surgery. Influential scientific and clinical experts stood together and evaluated the state of research and clinical application.
The keynote speaker in the conference was the Nobel Laureate Shinja Yamanaka. Dr Yamanaka won the award on 2012 for his creation of induced pluripotential stem cells. Yamanaka addressed among other things the importance of the regenerative medicine field opening a new frontier for the treatment of chronic degenerative conditions.
..Both companies, as leaders of the industry, launched their new Turnkey Solution, a compact and cohesive laboratory as a concept for physicians’ offices, and the new Progenikine Kit, an enzyme based closed system for isolation of adipose derived stem cells. To learn more, visit the Global Stem Cells Group website, www.stemcellsgroup.com.
https://www.stemcelltraining.net/global-stem-cells-group-participated-expositor-23rd-congress-isaps-2016-kyoto-japan/
https://time.com/5394912/stem-cell-treatment/?amp=true
Stem cells The Holy Grail Stansberry report!
..Doctors at St. Jude Children's Research Hospital used Mustang-developed "genetic surgery" to restore the broken immune systems of these eight infants afflicted with the disease. Stansberry Innovations Report editor Christian Olsen explained how this works in a private note on Friday...
First they extracted stem cells from a patient, then used a modified HIV virus to deliver and insert a healthy IL2RN gene into the stem cells, and then infused the modified stem cells back into the patient.
To get the patient ready to accept the changed cells, they were given a low dose of chemotherapy to prime the bone marrow. The bone marrow is what will produce blood cells from the genetically corrected stem cells and... Voila! Healthy immune system.
This may sound like science fiction. But it's not...
Gene therapy and editing is a real and growing trend you will hear about much more over the next several years. More from Christian...
This is real personalized medicine, which is the "Holy Grail." Cells were taken from a patient and used to create the treatment.
There is no doubt we are on the cusp of more of these success stories but, remember, at this stage we (at best) have a curative potential for "bubble boy" disease. There has to be more testing, but the news is incredibly promising.
So, MBIO shot up because it's the lead dog in this treatment tech, since it licensed it to treat patients at St. Jude.
https://stansberryresearch.com/articles/the-most-expensive-tech-stock-in-the-world-today-2
Oxford University
One of the greatest challenges of the 21st century is disease associated with ageing. Cancer, neurodegeneration and heart disease are all major causes of death and have an enormous impact on quality of life.
..Over recent years, a revolution in biology has meant that effective regenerative medicine, using stem cells to replace and repair damaged tissue is now on the horizon. Naturally occurring ‘immortal’ stem cells are present in all tissues of the body and act to replace loss of cells in tissues with rapid turnover, for example in the skin, blood or intestine, or to repair damage as in wound healing.
https://www.stemcells.ox.ac.uk/home
..Our human/mouse model demonstrated that proliferating hPSC-CPCs could reduce infract size and fibrosis resulting in formation of large grafts..
https://academic.oup.com/cardiovascres/advance-article/doi/10.1093/cvr/cvz181/5530198
..FDA says it’s unable to use the incomplete adverse event reporting data to quantify overall deaths that result from therapeutic drug use.
https://www.google.com/amp/s/health.usnews.com/health-news/patient-advice/articles/2016-09-27/the-danger-in-taking-prescribed-medications%3fcontext=amp
..“There has been an increased demand to develop effective drugs for cardiology and degenerative disorders, for which there were no effective treatment plans before the advent of stem therapies. The discovery of possible cardiac stem cells uncovered new arenas to repair hearts injured due to acute myocardial infarction or coronary artery disease,”
https://www.dailyprogress.com/opinion/opinion-commentary-global-stem-cell-therapy-market-to-showcase-growth/article_aeabbd8e-0106-11e7-a193-db25ffa753ac.amp.html
Harvard Stem Cell
..Our mission is to find cures for human diseases.
The Harvard community and the greater Boston area are home to the largest concentration of biomedical researchers in the world. This allows our network of over 1,000 scientists, from across Harvard and its eight affiliated hospitals, to advance stem cell biology and translational me
https://hsci.harvard.edu
Repairing the heart with stem cells
https://www.health.harvard.edu/heart-health/repairing-the-heart-with-stem-cells
Global Stem Cells Group and Adimarket to Represent Magellan in Latin America and Middle East.
https://www.prunderground.com/global-stem-cells-group-and-adimarket-to-represent-magellan-in-latin-america-and-middle-east/00112628/
Novas’ travel took him to Dubai, Oman and Kuwait where he met with investors and learned more about medical regulations in the region.
https://www.kuam.com/story/40113402/global-stem-cells-group-visits-middle-east-in-effort-to-expand-access-to-regenerative-medicine
Global Stem Cells Group has named Aesthetic Polyclinic in Abu Dhabi, UAE, exclusive representative for GSCG in that city.
https://www.prunderground.com/global-stem-cells-group-names-aesthetic-polyclinic-exclusive-representative-in-abu-dhabi/00109409/
Adimarket, has announced an agreement with biotechnology company Alolotl Biologix
..healing for a range of conditions, including orthopedic impairments, wound care, pain management, ophthalmic, cardiovascular, cosmetic, and more.
Human allograft under FDA regulation 21 CFR Part 1271 ..Immune privileged with anti-inflammatory and anti-bacterial properties
https://www.prunderground.com/adimarket-has-announced-an-agreement-with-biotechnology-company-alolotl-biologix/00114544/
Drug companies chase deals for cell and gene therapies, biotech's 'next wave'
..$20 billion in mergers and acquisitions in the cell and gene therapy space, or regenerative medicine, that year, according to the Alliance for Regenerative Medicine.
..FDA has "more than 800 active cell-based or directly administered gene therapy INDs on file."
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
..Stem Cell Banking Market to Witness Astonishing Growth
https://www.aglobalmarketresearch.com/stem-cell-banking-market-to-witness-astonishing-growth-of-10-cagr-by-2026-with-key-players-cord-blood-registry-cbr-systems-cordlife-group-limited-cryo-cell-international-viacord-cryo-save/
..Global Stem Cells Group Teams With CordónVida Servet Stem Cell Bank and Clinic to Organize the First International Symposium on Stem Cells and Regenerative Medicine
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.
Global Stem Cells Group, Inc. Announces Collaboration with VidaCel Laboratories and Stem Cell Bank, Chile..
http://stemcellcenter.net/global-stem-cells-group-inc-announces-collaboration-with-vidacel-laboratories-and-stem-cell-bank-chile/
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.htm
GSCG ISSCA Launch Dates.
•Santiago de Chile, Chile: September 5, 2019
•Bogota, Colombia: October 4, 2019
•Buenos Aires, Argentina: October 11, 2019
•Miami, Florida (in English): November 1, 2019
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149621212
..GSCG Knee Osteoarthrithis, Mayo Clinic Stem cell arthritis!
Mayo Clinic uses stem cell therapy to treat arthritis in knee
http://medprofvideos.mayoclinic.org/videos/mayo-clinic-uses-stem-cell-therapy-to-treat-arthritis-in-knee
Studies a U.S. FDA-regulated Device Product: YES
Estimated Study Start Date : May 13, 2019
Estimated Primary Completion Date : September 15, 2020
Estimated Study Completion Date : November 1, 2020
https://clinicaltrials.gov/ct2/show/NCT03752827
Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/
Nearly a decade of stem cell therapy experience
The cell is the minimal body’s representation, it is the basic unit for the living species where all the vital functions happen such as respiration, nutrition, and reproduction.
The STEM CELL is a special cell that normally circulates in the body, responsible for regenerating naturally the deteriorating organs. This treatment seeks for the stem cells to differentiate or become healthy cells from damaged or defective tissue to improve the function of the diseased organ.
http://cellgenic.com/
Exosomes are currently non-reactive and FDA approved.
ADIMARKET..Flow uses exosomes in compliance with US regulations to provide innovative treatment options to those suffering from degenerative diseases.
..Exosomes provide an exciting new treatment option for those suffering from degenerative diseases.
https://www.abc-7.com/story/40368805/adimarket-releases-new-exosomes-product-that-delivers-therapeutic-promise
LAHO!..CEO Announces..New Stem Cell Center in Valencia, Spain
..“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1376239
....“Our objective is to bring this cutting-edge3D bioprinting technology to scientists and regenerative medicine researcher..
https://www.facebook.com/pg/globalstemcells/photos/?ref=page_internal
LAHO CEO Dave Christensen highly skilled.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149320841
..ISSCA Set to Host Regenerative Medicine Symposium in Buenos Aires
https://www.stemcellsgroup.com/
Adimarket featured products!
Magellan PRP The Magellan® technology
32” Portable Clean Room $4,500.00
INKREDIBLE 3D BIOPRINTER
BEAR C2202 Centrifuge $3,000.00
Shockwave Machine $3,500.00
H.I.F.U High Intensity Focused Ultrasound $7,500.00
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149417821
https://www.adimarket.net/product-category/in-office-processing-equipment/
Global Stem Cells Group CEO Benito Novas is driven by his passion for helping physicians and scientists change the world through stem cell medicine. Dedicated to creating critical organizational systems that ensure success, he is an expert in the field of specialized marketing focused on Biotechnology, Life Sciences, and Healthcare development.
http://www.stemcellsgroup.com/management/
Global Stem Cells Group’s Benito Novas Announces Agreement with Clinica Planas
..The ongoing partnership will offer certification in regenerative medicine for European-based medical practitioners .
https://www.stemcellsgroup.com/benito-novas-announces-agreement-with-clinica-
https://cursocelulasmadre.com/entrenamiento-en-
GSCG is #1 Competitor for Biostems Tech $1.52
Dark Defunct
GCSG is #1 competitor for Beike Biotechnology.
GSCG is #1 competitor of Global Institute Of Stem Cell Therapy And Research!
..Stem cells are jacks of all trades, capable of alleviating the consequences of such diverse pathologies as heart attacks, strokes and cancer.
..In a new study, Yale researchers succeeded in doing so, opening the door to new stem cell-inspired, cell-free treatments for the effects of a heart attack.
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
“Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth,” says the US National Institutes of Health. “In many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive
Market cap: $2.09 billion; current share price: $24.25
Market cap: $226.15 Million; current share price: $1.83
Market cap: $161.84 million; current share price: $1.47
Market cap: $267.60 million; current share price: $19.10
Market cap: $392.71 million; current share price: $11.25
Market cap: $64.63 million; current share price: $3.43
Market cap: $54.74 million; current share price: $5.78
Market cap: $11.05 million; current share price: $0.31
Market cap: $29.88 million; current share price: $2.75
Market cap: $28.40 million; current share price: $1.30
https://investingnews.com/daily/life-science-investing/genetics-investing/top-stem-cell-nasdaq/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149422974
http://www.stemcellsgroup.com/adimarket-launches-website/
..Bioheart, Inc. (otcqb:BHRT), a biotech company focused on the discovery, development and commercialization of autologous cell therapies, has announced that it has initiated a new clinical site in collaboration with Global Stem Cell Group in Cozumel, Mexico. The two companies have successfully treated their first congestive heart failure patient at the new clinical site last week using Bioheart's AdipoCell (adipose derived stem cells).
https://www.marketwatch.com/press-release/bioheart-announces-new-clinical-site-in-mexico-2013-11-25
Advancells ties up with Global Stem Cells Group
https://ehealth.eletsonline.com/2015/03/advancells-ties-global-stem-cells-group/amp/
Global Stem Cells Group and Kimera Labs Announce Autologous Stem Cell Research Alliance
https://www.streetinsider.com/dr/news.php?id=11539116
Global Stem Cells Group's Chile Facility Expected to Receive Regenetech RTA Certification
https://www.newswire.com/news/global-stem-cells-groups-chile-facility-expected-to-receive-regenetech-rta
Global Stem Cells Group to Host Stem Cells and Regenerative ...
ISSCA Physicians looking for new alternatives to improve the quality of life of their patients through emerging regenerative medicine protocols..
https://www.issca.us/stem-cells-and-regenerative-medicine-conference-in-miami/
“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
In opening the new center, the GSCG has signed an agreement with Dra. Laura Maria Caicedo, medical director of the Instituto Valenciano MEDEC (https://medec.es/conoce-medec/#equipoMedico). Dr. Caicedo is a specialist on hair loss with an interest in delivering stem cell based treatments to her patients and others in Valencia.
https://medec.es/conoce-medec/#equipoMedico
http://www.stemcellsgroup.com
Barcelona, Spain
J. Victor Garcia Gimenez, M.D. is president of Therapeutic Confrontations (CONFTERA), is a specialist in orthopedic surgery and practices cosmetic medicine and surgery, anti-aging medicine, and aesthetic therapies in Barcelona, Spain.
http://stemcellcenter.net/centers/spain/barcelona/barcelona-spain/\
GSCG..ISSCA Reaches Agreement with Belgium’s Churchill Aesthetic Center
..The International Society for Stem Cell Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and...
Friday, June 21st 2019, 12:32 PM CDT
The innovative new center will provide training in regenerative medicine for doctors located in Belgium and France.
..We look forward to ISSCA’s exciting new partnership with Belgium’s Churchill Aesthetic Center and the possibilities it brings in delivering safe and effective regenerative medicine treatment options to more patients across the globe,” said Benito Novas, CEO of the Global Stem Cells Group.
https://www.newschannelnebraska.com/story/40691664/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center
https://www.churchill-aesthetic-center.be/autres-specialites/
....The cutting-edge facility will be equipped by Adimarket, LLC, a subsidiary of the Global Stem Cells Group. Adimarket will outfit the center with equipment and supplies designed to not only teach doctors about the latest protocols in regenerative medicine but also to treat patients suffering from degenerative diseases and sports injuries. Physicians training at the facility will have access to the proven expertise of ISSCA’s global network and training protocols.
http://www.stemcellsgroup.com/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center/
Daeyong Kim, Ph.D. is an internationally recognized health educator, and CEO of N-Biotek, Inc, a preeminent manufacturer of biomedical and laboratory equipment. N-Biotek is a leader of stem cell technologies, providing solutions for providers worldwide.
..Dr. Zhang is an accomplished scientist, microbiologist and virologist who has worked extensively in the U.S. for the CDC, the National Institutes of Health (NIH) and the US Food and Drug Administration in various research positions, including senior associate at the National Research Center. A Chinese-American, Dr. Zhang received the Award for Scientific Achievement from the FDA
..Al Sears, M.D. often referred to as "America’s #1 anti-aging doctor," is the director of the world renowned Sears Institute for Anti-aging Medicine. Dr. Sears has published 35 books and reports on health and wellness, and has millions of loyal readers in 163 countries. Dr. Sears has been featured on ABC News, CNN and ESPN. He was one of the first specialists to be board-certified by the American Academy of Anti-Aging Medicine (A4M).
Dr. Feinerman offers stem cell treatments for a variety of disorders and diseases. He earned his medical degree from New York Medical College in 1954. Dr. Feinerman is affiliated with Long Island College Hospital in New York and Mayo Clinic in Rochester, Minnesota.
Dr. Feinerman is a member of the Society of Apheresis, Society of Bone Marrow Blood Transplantation, and the International Society for Cellular Therapy, the Society for Cranial Transplantation and Brain Repair and the Society for Cardiac Translational Therapy.
http://www.stemcellsgroup.com/advisory-board/
Stem Data - The First Clinical Record of Regenerative Medicine in the Cloud.
http://stemdata.org
State-Of-The-Art Equipment
We’ll set you up with the best equipment you need to process stem cells and carry out the regenerative procedures for your patients..
http://stemcellslab.net/facility-and-equipment/
http://stemcellcenter.net/programs/
GLTA $LAHO GSCG
$LAHO..GSCG has named Aesthetic Polyclinic in Abu Dhabi, UAE, exclusive representative for GSCG in that city.
Global Stem Cells Group and Adimarket to Represent Magellan in Latin America and Middle East.
https://www.prunderground.com/global-stem-cells-group-and-adimarket-to-represent-magellan-in-latin-america-and-middle-east/00112628/
Novas’ travel took him to Dubai, Oman and Kuwait where he met with investors and learned more about medical regulations in the region.
https://www.kuam.com/story/40113402/global-stem-cells-group-visits-middle-east-in-effort-to-expand-access-to-regenerative-medicine
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149649599
$LAHO “Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth,” says the US National Institutes of Health. “In many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive
Market cap: $2.09 billion; current share price: $24.25
Market cap: $226.15 Million; current share price: $1.83
Market cap: $161.84 million; current share price: $1.47
Market cap: $267.60 million; current share price: $19.10
Market cap: $392.71 million; current share price: $11.25
Market cap: $64.63 million; current share price: $3.43
Market cap: $54.74 million; current share price: $5.78
Market cap: $11.05 million; current share price: $0.31
Market cap: $29.88 million; current share price: $2.75
Market cap: $28.40 million; current share price: $1.30
https://investingnews.com/daily/life-science-investing/genetics-investing/top-stem-cell-nasdaq/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149422974
Facility And Equipment
http://stemcellslab.net/facility-and-equipment/
$LAHO
$LAHO ..Global Stem..Market to Reach US$ 467 billion by 2024 ..Due to the increased funding from Government and Private sector and rising global awareness.
https://www.marketwatch.com/press-release/global-stem-cells-market-is-determined-to-reach-us-467-billion-by-2024-2019-03-05
Regenerative medicine will dramatically alter the U.S. healthcare industry
..Because of the economic potential of this industry (the worldwide market for regenerative medicine is conservatively estimated to be $500 billion..
An example of some conditions and diseases that could be easily cured by regenerative medicine and their current cost of treatmentt include:
250,000 patients receive heart valves, at a cost of $27 billion annually
950,000 people die of heart disease or stroke, at a cost of $351 billion annually(8)
17 million patients with diabetes, at a cost of $132 billion annually
..By doing so, we can make tissue and organ failure a relic of the past by 2020.
Interagency Federal Working Group on Regenerative Medicine
Chair
Howard Zucker, MD, JD
Deputy Assistant Secretary for Health
U.S. Department of Health and Human Services
National Institutes of Health
Donna Dean, PhD
Colleen Guay-Broder, MPH
Eleni Kousvelari, PhD
Christine Kelley, PhD
John Watson, PhD
Josh Zimmerberg, PhD
Food and Drug Administration
Charles Durfor, PhD
Donald Fink, PhD
Joyce Frey, PhD
Jesse Goodman, MD
Darin Weber, PhD
Celia Witten, PhD
http://singularity-2045.org/HHS-regenerative-medicine-2020-vision-archive-2014.html
Adimarket 119 pages Medical devices!
https://2nvdue1pi3s51uaik42s7kgz-wpengine.netdna-ssl.com/wp-content/uploads/2017/05/ADIMarket_1.pdf
Studies a U.S. FDA-regulated Device Product: YES
Estimated Study Start Date : May 13, 2019
Estimated Primary Completion Date : September 15, 2020
Estimated Study Completion Date : November 1, 2020
https://clinicaltrials.gov/ct2/show/NCT03752827
Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/
$LAHO
$LAHO ..upsurge in venture capital investment..growth of 7,300%
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
..Regenerative medicine will dramatically alter the U.S. healthcare industry
http://singularity-2045.org/HHS-regenerative-medicine-2020-vision-archive-2014.html
..This may sound like science fiction. But it's not...
Gene therapy and editing is a real and growing trend you will hear about much more over the next several years. More from Christian...
This is real personalized medicine, which is the "Holy Grail.
https://stansberryresearch.com/articles/the-most-expensive-tech-stock-in-the-world-today-2
Oxford
a revolution in biology has meant that effective regenerative medicine, using stem cells to replace and repair damaged tissue is now on the horizon.
https://www.stemcells.ox.ac.uk/home
$LAHO
$LAHO..USDHHS..conservatively estimated to be $500 billion..
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150088612
$LAHO
$LAHO awesome rocket ship eruption LOL
The potential impact of stem cell research on human health is enormous.
https://medicine.yale.edu/stemcell/people/research/therapy.aspx
https://medicine.yale.edu/news/medicineatyale/a-shangrila-for-stem-cell-research-at-yale.aspx
Alzheimer’s Cure
We are working toward achieving this goal by using stem cells to study the actual human cells affected by the disease and discern its underlying causes.
https://nyscf.org/research-institute/disease-focuses/alzheimers-disease/
Medical researchers believe that stem cell treatments have the potential to change the face of human disease and alleviate suffering.
https://www.sciencedaily.com/terms/stem_cell_treatments.htm
Types of Stem Cell Transplants for Cancer Treatment
https://www.cancer.org/treatment/treatments-and-side-effects/treatment-types/stem-cell-transplant/types-of-transplants.html
making the benefits of stem cell medicine a reality for both doctors and patients worldwide.
Through Stem Cell Training, Inc., we provide intensive, hands-on stem cell training to qualified physicians and high level medical professionals worldwide, which includes regenerative medicine fundamentals and the latest cellular medicine protocols. Through our stem cell training programs, physicians are able to provide life-changing medical solutions for patients in their office or clinical setting. Through Stem Cell Training Inc., we share the latest methods, know-how, and technological facilities with medical professionals. We offer courses, seminars, and workshops year round on stem cell therapy and treatments.
Through AdiMarket, we provide an online resource center for biomedical products and equipment needed to conduct stem cell therapies in office or clinic. AdiMarket is staffed by knowledgeable attendants to help each physician fulfill their specific product and equipment needs.
GSCG’s Stem Cell Center is a one-of-a-kind worldwide medical practice network of highly qualified, experienced physicians who provide stem cell solutions within their areas of practice. Stem Cell Center is the largest membership network of regenerative medicine clinics in the world, providing cutting edge care with the latest advancements in cellular therapies to patients worldwide. Stem Cell Center's mission is to make the promise of stem cell medicine become a reality for patients around the world.
Stem Data is a powerful Regenerative medicine Practice Management System designed to be an all-in-one, easy-to-use, intuitive, patient data management software for any healthcare environment.
And finally our Stem Cell laboratory Division offers a turn key state of the art stem cell processing center allowing our clients to conduct research and perform highly advanced stem cell procedures.
http://www.stemcellsgroup.com/our-story/
$LAHO
$LAHO Good info, also Benito is in Spain photos in facebook!
..Adimarket, LLC, a subsidiary of the Global Stem Cells Group is a leading distributor of products for regenerative medicine providers, has announced a new stem cells product, exosomes, to its product portfolio.
..Exosomes are currently non-reactive and FDA approved.
https://www.kitv.com/story/40368805/adimarket-releases-new-exosomes-product-that-delivers-therapeutic-promise
Adimarket announces launch of Cellgenic stem cell protein extract hair restoration product
https://www.stemcelltraining.net/cadpe-stem-cell-hair-restoration-application/
$LAHO Stem Cells is the future of medicine!
$LAHO..Stem Data - The First Clinical Record of Regenerative Medicine in the Cloud.
http://stemdata.org
The Stem Cell Group
@StemCellGroupUS
We've brought together eight companies on the cutting edge of #healing into one global network.
https://mobile.twitter.com/StemCellGroupUS
Science Newsfrom research organizations
On the immortality of stem cells
Date:March 7, 2018
Source: University of Cologne
Summary:Stem cells are considered to be immortal in culture and, therefore, of great interest for aging research. This immortality is regulated by increased proteostasis, which controls the quality of proteins. A team of researchers found a link between increased proteostasis and immortality of human embryonic stem cells
https://www.sciencedaily.com/releases/2018/03/180307101033.htm
$LAHO
$LAHO GSCG #1..Top Competitors of Beike Biotechnology Co. Ltd
$80M 400 employees..
1.Global Stem Cells Group
https://www.zoominfo.com/c/beike-biotechnology-co-ltd/25333101
..Currently Beike Biotechnology has the world’s largest, most comprehensive data-based clinical safety and efficacy study database (consisting of more than 80,000 people) and an integrated research system.
https://beikebiotech.com/blog/2015/01/04/source-concord-acquires-beike-biotechnology-shares/
$LAHO measured as deserved!
$LAHO..SEC FILED 8K RM..Future of Medicine 36 Stem Centers, 27 COUNTRIES
Lans Holdings, Inc.
Our Email is:-investors@lansholdings.com
investors@lans.holdings
info@lansholdings.com
bizdev@lansholdings.com
For further information, please contact:
Telephone: +1.786.786.5758 and 305-755-7451
https://www.otcmarkets.com/stock/LAHO/disclosure
..(GSCG)..binding letter..to sell 100% to Lans Holdings Inc. (OTCPink: LAHO)
https://www.stemcellsgroup.com/lans-holdings-enters-into-binding-loi-to-acquire-global-stem-cells-group/
SEC filed.. penalty of $500,000 for the party that breaches terms of the binding LOI.
Lans Holdings Successfully Completes Due Diligence of Global Stem Cells Group
https://www.otcmarkets.com/stock/LAHO/news
$24.4M Zoominfo Prior Q
https://www.zoominfo.com/c/global-stem-cells-group-inc/357592775
AdiMarket $10M
1 of 27 Facilities, Stem Cells Group Chile $5.6M!
We’re positioning Adimarket to become the largest e-commerce marketplace for all things regenerative medicine,” says Benito Novas, founder and CEO of Global Stem Cells Group.
http://www.stemcellsgroup.com/adimarket-launches-website/
..Stem Cell Center, Inc. is the world's largest collective support & advisory network of regenerative medicine clinics and and physicians
http://stemcellcenter.net/
ADMIMARKET BIOTECHNOLOGY BIOMEDICAL EQUIPMENT CATALOGUE
https://2nvdue1pi3s51uaik42s7kgz-wpengine.netdna-ssl.com/wp-content/uploads/2017/05/ADIMarket_1.pdf
Advisory board!
http://adimarket.info/advisory-board/
https://stemcellsgroup.cl/scg/
http://stemcellcenter.net/
http://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=OfficerRegisteredAgentName&directionType=Initial&searchNameOrder=NOVASBENITO%20L120000749410&aggregateId=flal-l12000074941-c51a8233-2938-4f22-b6c7-c111a2e55ddc&searchTerm=Novasanos&listNameOrder=NOVASANOS%20F120000001373
https://www.marketwatch.com/press-release/global-stem-cell-therapy-market-insight-business-evaluation-dimension-industry-grow-at-cagr-of-3652-trends-and-forecasts-2018-2023-2019-03-06
..upsurge in venture capital investment represents growth of 7,300%
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
Regenerative medicine..USDHHS..conservatively estimated..$500 billion by 2020
Regenerative medicine will dramatically alter the U.S. healthcare industry
..Because of the economic potential of this industry (the worldwide market for regenerative medicine is conservatively estimated to be $500 billion..
An example of some conditions and diseases that could be easily cured by regenerative medicine and their current cost of treatmentt include:
250,000 patients receive heart valves, at a cost of $27 billion annually
950,000 people die of heart disease or stroke, at a cost of $351 billion annually(8)
17 million patients with diabetes, at a cost of $132 billion annually
..By doing so, we can make tissue and organ failure a relic of the past by 2020.
Interagency Federal Working Group on Regenerative Medicine
Chair
Howard Zucker, MD, JD
Deputy Assistant Secretary for Health
U.S. Department of Health and Human Services
National Institutes of Health
Donna Dean, PhD
Colleen Guay-Broder, MPH
Eleni Kousvelari, PhD
Christine Kelley, PhD
John Watson, PhD
Josh Zimmerberg, PhD
Food and Drug Administration
Charles Durfor, PhD
Donald Fink, PhD
Joyce Frey, PhD
Jesse Goodman, MD
Darin Weber, PhD
Celia Witten, PhD
http://singularity-2045.org/HHS-regenerative-medicine-2020-vision-archive-2014.html
Global Stem..Market to Reach US$ 467 billion by 2024 ..Due to the increased funding from Government and Private sector and rising global awareness.
https://www.marketwatch.com/press-release/global-stem-cells-market-is-determined-to-reach-us-467-billion-by-2024-2019-03-05
The Shiller P/E is a more reasonable market valuation indicator than the P/E ratio because it eliminates fluctuation of the ratio caused by the variation of profit margins during business cycles.
Sector Healthcare: 30.50
Sector Technology: 34.40
https://www.gurufocus.com/shiller-PE.php
http://www.econ.yale.edu/~shiller/
BioTechnology
https://www.nasdaq.com/press-release/laho-global-stem-cells-group-announces-opening-of-two-new-stem-cell-centers-20190612-00503
GSCG Attorney ERIC P. GROS-DUBOIS Flawless AVVO!
https://www.avvo.com/attorneys/33135-fl-eric-grosdubois-3340017.html
Eric P. Gros-Dubois, Esq.
Founding Partner
eric@epgdlaw.com
Executive Committee and Board Member of the Coral Gables Chamber of Commerce, former President of the Rotary Club of Brickell, current President of BNI Coral Gables, past president of his home owner’s association, and supporter of many fundraisers devoted to the community. Eric also regularly teaches other lawyers for their continuing legal education, presents to The American Immigration Lawyers Association, and more.
Washington College of Law. Juris Doctor (JD)
Kogod School of Business. Masters in Business Administration (MBA)
Southern Methodist University. Bachelor of Arts (BA). Sigma Chi Fraternity
Jesuit College Preparatory School, Dallas
Bar Admissions:
State of New York
State of Maryland
District of Columbia
State of Florida
Federal District Court for the Southern District of Florida
Federal District Court for Maryland
U.S. Tax Court
CLE Lecture: “The New Tax Rules for Mergers and Acquisitions.” June, 2018
https://www.epgdlaw.com/eric-p-gros-dubois/
https://www.floridabar.org/directories/find-mbr/profile/?num=83381
Scientists Are Developing New Ways to Treat Disease With Cells, Not Drugs
https://www.cancerresearch.org/blog/december-2018/james-allison-nobel-postdoc-fellow-perspectives
GSCG conference in Japan..
..After receiving a personal invitation from President Susumu Takayangi MD, Global Stem Cells Group and its Korean biotechnology partner, N-Biotek, participated in the 23rd Congress of the International Society of Aesthetic Plastic Surgeons that took place this October in Kyoto.
The Congress brought together an expert panel for a series of lectures and discussions that hope to provide solutions and create new techniques in the coming years to be applied in plastic and reconstructive surgery. Influential scientific and clinical experts stood together and evaluated the state of research and clinical application.
The keynote speaker in the conference was the Nobel Laureate Shinja Yamanaka. Dr Yamanaka won the award on 2012 for his creation of induced pluripotential stem cells. Yamanaka addressed among other things the importance of the regenerative medicine field opening a new frontier for the treatment of chronic degenerative conditions.
..Both companies, as leaders of the industry, launched their new Turnkey Solution, a compact and cohesive laboratory as a concept for physicians’ offices, and the new Progenikine Kit, an enzyme based closed system for isolation of adipose derived stem cells. To learn more, visit the Global Stem Cells Group website, www.stemcellsgroup.com.
https://www.stemcelltraining.net/global-stem-cells-group-participated-expositor-23rd-congress-isaps-2016-kyoto-japan/
https://time.com/5394912/stem-cell-treatment/?amp=true
Stem cells The Holy Grail Stansberry report!
..Doctors at St. Jude Children's Research Hospital used Mustang-developed "genetic surgery" to restore the broken immune systems of these eight infants afflicted with the disease. Stansberry Innovations Report editor Christian Olsen explained how this works in a private note on Friday...
First they extracted stem cells from a patient, then used a modified HIV virus to deliver and insert a healthy IL2RN gene into the stem cells, and then infused the modified stem cells back into the patient.
To get the patient ready to accept the changed cells, they were given a low dose of chemotherapy to prime the bone marrow. The bone marrow is what will produce blood cells from the genetically corrected stem cells and... Voila! Healthy immune system.
This may sound like science fiction. But it's not...
Gene therapy and editing is a real and growing trend you will hear about much more over the next several years. More from Christian...
This is real personalized medicine, which is the "Holy Grail." Cells were taken from a patient and used to create the treatment.
There is no doubt we are on the cusp of more of these success stories but, remember, at this stage we (at best) have a curative potential for "bubble boy" disease. There has to be more testing, but the news is incredibly promising.
So, MBIO shot up because it's the lead dog in this treatment tech, since it licensed it to treat patients at St. Jude.
https://stansberryresearch.com/articles/the-most-expensive-tech-stock-in-the-world-today-2
Oxford University
One of the greatest challenges of the 21st century is disease associated with ageing. Cancer, neurodegeneration and heart disease are all major causes of death and have an enormous impact on quality of life.
..Over recent years, a revolution in biology has meant that effective regenerative medicine, using stem cells to replace and repair damaged tissue is now on the horizon. Naturally occurring ‘immortal’ stem cells are present in all tissues of the body and act to replace loss of cells in tissues with rapid turnover, for example in the skin, blood or intestine, or to repair damage as in wound healing.
https://www.stemcells.ox.ac.uk/home
..Our human/mouse model demonstrated that proliferating hPSC-CPCs could reduce infract size and fibrosis resulting in formation of large grafts..
https://academic.oup.com/cardiovascres/advance-article/doi/10.1093/cvr/cvz181/5530198
..FDA says it’s unable to use the incomplete adverse event reporting data to quantify overall deaths that result from therapeutic drug use.
https://www.google.com/amp/s/health.usnews.com/health-news/patient-advice/articles/2016-09-27/the-danger-in-taking-prescribed-medications%3fcontext=amp
..“There has been an increased demand to develop effective drugs for cardiology and degenerative disorders, for which there were no effective treatment plans before the advent of stem therapies. The discovery of possible cardiac stem cells uncovered new arenas to repair hearts injured due to acute myocardial infarction or coronary artery disease,”
https://www.dailyprogress.com/opinion/opinion-commentary-global-stem-cell-therapy-market-to-showcase-growth/article_aeabbd8e-0106-11e7-a193-db25ffa753ac.amp.html
Harvard Stem Cell
..Our mission is to find cures for human diseases.
The Harvard community and the greater Boston area are home to the largest concentration of biomedical researchers in the world. This allows our network of over 1,000 scientists, from across Harvard and its eight affiliated hospitals, to advance stem cell biology and translational me
https://hsci.harvard.edu
Repairing the heart with stem cells
https://www.health.harvard.edu/heart-health/repairing-the-heart-with-stem-cells
Global Stem Cells Group and Adimarket to Represent Magellan in Latin America and Middle East.
https://www.prunderground.com/global-stem-cells-group-and-adimarket-to-represent-magellan-in-latin-america-and-middle-east/00112628/
Novas’ travel took him to Dubai, Oman and Kuwait where he met with investors and learned more about medical regulations in the region.
https://www.kuam.com/story/40113402/global-stem-cells-group-visits-middle-east-in-effort-to-expand-access-to-regenerative-medicine
Global Stem Cells Group has named Aesthetic Polyclinic in Abu Dhabi, UAE, exclusive representative for GSCG in that city.
https://www.prunderground.com/global-stem-cells-group-names-aesthetic-polyclinic-exclusive-representative-in-abu-dhabi/00109409/
Adimarket, has announced an agreement with biotechnology company Alolotl Biologix
..healing for a range of conditions, including orthopedic impairments, wound care, pain management, ophthalmic, cardiovascular, cosmetic, and more.
Human allograft under FDA regulation 21 CFR Part 1271 ..Immune privileged with anti-inflammatory and anti-bacterial properties
https://www.prunderground.com/adimarket-has-announced-an-agreement-with-biotechnology-company-alolotl-biologix/00114544/
Drug companies chase deals for cell and gene therapies, biotech's 'next wave'
..$20 billion in mergers and acquisitions in the cell and gene therapy space, or regenerative medicine, that year, according to the Alliance for Regenerative Medicine.
..FDA has "more than 800 active cell-based or directly administered gene therapy INDs on file."
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
..Stem Cell Banking Market to Witness Astonishing Growth
https://www.aglobalmarketresearch.com/stem-cell-banking-market-to-witness-astonishing-growth-of-10-cagr-by-2026-with-key-players-cord-blood-registry-cbr-systems-cordlife-group-limited-cryo-cell-international-viacord-cryo-save/
..Global Stem Cells Group Teams With CordónVida Servet Stem Cell Bank and Clinic to Organize the First International Symposium on Stem Cells and Regenerative Medicine
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.
Global Stem Cells Group, Inc. Announces Collaboration with VidaCel Laboratories and Stem Cell Bank, Chile..
http://stemcellcenter.net/global-stem-cells-group-inc-announces-collaboration-with-vidacel-laboratories-and-stem-cell-bank-chile/
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.htm
GSCG ISSCA Launch Dates.
•Santiago de Chile, Chile: September 5, 2019
•Bogota, Colombia: October 4, 2019
•Buenos Aires, Argentina: October 11, 2019
•Miami, Florida (in English): November 1, 2019
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149621212
..GSCG Knee Osteoarthrithis, Mayo Clinic Stem cell arthritis!
Mayo Clinic uses stem cell therapy to treat arthritis in knee
http://medprofvideos.mayoclinic.org/videos/mayo-clinic-uses-stem-cell-therapy-to-treat-arthritis-in-knee
Studies a U.S. FDA-regulated Device Product: YES
Estimated Study Start Date : May 13, 2019
Estimated Primary Completion Date : September 15, 2020
Estimated Study Completion Date : November 1, 2020
https://clinicaltrials.gov/ct2/show/NCT03752827
Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/
Nearly a decade of stem cell therapy experience
The cell is the minimal body’s representation, it is the basic unit for the living species where all the vital functions happen such as respiration, nutrition, and reproduction.
The STEM CELL is a special cell that normally circulates in the body, responsible for regenerating naturally the deteriorating organs. This treatment seeks for the stem cells to differentiate or become healthy cells from damaged or defective tissue to improve the function of the diseased organ.
http://cellgenic.com/
Exosomes are currently non-reactive and FDA approved.
ADIMARKET..Flow uses exosomes in compliance with US regulations to provide innovative treatment options to those suffering from degenerative diseases.
..Exosomes provide an exciting new treatment option for those suffering from degenerative diseases.
https://www.abc-7.com/story/40368805/adimarket-releases-new-exosomes-product-that-delivers-therapeutic-promise
LAHO!..CEO Announces..New Stem Cell Center in Valencia, Spain
..“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1376239
....“Our objective is to bring this cutting-edge3D bioprinting technology to scientists and regenerative medicine researcher..
https://www.facebook.com/pg/globalstemcells/photos/?ref=page_internal
LAHO CEO Dave Christensen highly skilled.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149320841
..ISSCA Set to Host Regenerative Medicine Symposium in Buenos Aires
https://www.stemcellsgroup.com/
Adimarket featured products!
Magellan PRP The Magellan® technology
32” Portable Clean Room $4,500.00
INKREDIBLE 3D BIOPRINTER
BEAR C2202 Centrifuge $3,000.00
Shockwave Machine $3,500.00
H.I.F.U High Intensity Focused Ultrasound $7,500.00
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149417821
https://www.adimarket.net/product-category/in-office-processing-equipment/
Global Stem Cells Group CEO Benito Novas is driven by his passion for helping physicians and scientists change the world through stem cell medicine. Dedicated to creating critical organizational systems that ensure success, he is an expert in the field of specialized marketing focused on Biotechnology, Life Sciences, and Healthcare development.
http://www.stemcellsgroup.com/management/
Global Stem Cells Group’s Benito Novas Announces Agreement with Clinica Planas
..The ongoing partnership will offer certification in regenerative medicine for European-based medical practitioners .
https://www.stemcellsgroup.com/benito-novas-announces-agreement-with-clinica-
https://cursocelulasmadre.com/entrenamiento-en-
GSCG is #1 Competitor for Biostems Tech $1.52
Dark Defunct
GCSG is #1 competitor for Beike Biotechnology.
GSCG is #1 competitor of Global Institute Of Stem Cell Therapy And Research!
..Stem cells are jacks of all trades, capable of alleviating the consequences of such diverse pathologies as heart attacks, strokes and cancer.
..In a new study, Yale researchers succeeded in doing so, opening the door to new stem cell-inspired, cell-free treatments for the effects of a heart attack.
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
“Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth,” says the US National Institutes of Health. “In many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive
Market cap: $2.09 billion; current share price: $24.25
Market cap: $226.15 Million; current share price: $1.83
Market cap: $161.84 million; current share price: $1.47
Market cap: $267.60 million; current share price: $19.10
Market cap: $392.71 million; current share price: $11.25
Market cap: $64.63 million; current share price: $3.43
Market cap: $54.74 million; current share price: $5.78
Market cap: $11.05 million; current share price: $0.31
Market cap: $29.88 million; current share price: $2.75
Market cap: $28.40 million; current share price: $1.30
https://investingnews.com/daily/life-science-investing/genetics-investing/top-stem-cell-nasdaq/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149422974
http://www.stemcellsgroup.com/adimarket-launches-website/
..Bioheart, Inc. (otcqb:BHRT), a biotech company focused on the discovery, development and commercialization of autologous cell therapies, has announced that it has initiated a new clinical site in collaboration with Global Stem Cell Group in Cozumel, Mexico. The two companies have successfully treated their first congestive heart failure patient at the new clinical site last week using Bioheart's AdipoCell (adipose derived stem cells).
https://www.marketwatch.com/press-release/bioheart-announces-new-clinical-site-in-mexico-2013-11-25
Advancells ties up with Global Stem Cells Group
https://ehealth.eletsonline.com/2015/03/advancells-ties-global-stem-cells-group/amp/
Global Stem Cells Group and Kimera Labs Announce Autologous Stem Cell Research Alliance
https://www.streetinsider.com/dr/news.php?id=11539116
Global Stem Cells Group's Chile Facility Expected to Receive Regenetech RTA Certification
https://www.newswire.com/news/global-stem-cells-groups-chile-facility-expected-to-receive-regenetech-rta
Global Stem Cells Group to Host Stem Cells and Regenerative ...
ISSCA Physicians looking for new alternatives to improve the quality of life of their patients through emerging regenerative medicine protocols..
https://www.issca.us/stem-cells-and-regenerative-medicine-conference-in-miami/
“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
In opening the new center, the GSCG has signed an agreement with Dra. Laura Maria Caicedo, medical director of the Instituto Valenciano MEDEC (https://medec.es/conoce-medec/#equipoMedico). Dr. Caicedo is a specialist on hair loss with an interest in delivering stem cell based treatments to her patients and others in Valencia.
https://medec.es/conoce-medec/#equipoMedico
http://www.stemcellsgroup.com
Barcelona, Spain
J. Victor Garcia Gimenez, M.D. is president of Therapeutic Confrontations (CONFTERA), is a specialist in orthopedic surgery and practices cosmetic medicine and surgery, anti-aging medicine, and aesthetic therapies in Barcelona, Spain.
http://stemcellcenter.net/centers/spain/barcelona/barcelona-spain/\
GSCG..ISSCA Reaches Agreement with Belgium’s Churchill Aesthetic Center
..The International Society for Stem Cell Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and...
Friday, June 21st 2019, 12:32 PM CDT
The innovative new center will provide training in regenerative medicine for doctors located in Belgium and France.
..We look forward to ISSCA’s exciting new partnership with Belgium’s Churchill Aesthetic Center and the possibilities it brings in delivering safe and effective regenerative medicine treatment options to more patients across the globe,” said Benito Novas, CEO of the Global Stem Cells Group.
https://www.newschannelnebraska.com/story/40691664/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center
https://www.churchill-aesthetic-center.be/autres-specialites/
....The cutting-edge facility will be equipped by Adimarket, LLC, a subsidiary of the Global Stem Cells Group. Adimarket will outfit the center with equipment and supplies designed to not only teach doctors about the latest protocols in regenerative medicine but also to treat patients suffering from degenerative diseases and sports injuries. Physicians training at the facility will have access to the proven expertise of ISSCA’s global network and training protocols.
http://www.stemcellsgroup.com/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center/
Daeyong Kim, Ph.D. is an internationally recognized health educator, and CEO of N-Biotek, Inc, a preeminent manufacturer of biomedical and laboratory equipment. N-Biotek is a leader of stem cell technologies, providing solutions for providers worldwide.
..Dr. Zhang is an accomplished scientist, microbiologist and virologist who has worked extensively in the U.S. for the CDC, the National Institutes of Health (NIH) and the US Food and Drug Administration in various research positions, including senior associate at the National Research Center. A Chinese-American, Dr. Zhang received the Award for Scientific Achievement from the FDA
..Al Sears, M.D. often referred to as "America’s #1 anti-aging doctor," is the director of the world renowned Sears Institute for Anti-aging Medicine. Dr. Sears has published 35 books and reports on health and wellness, and has millions of loyal readers in 163 countries. Dr. Sears has been featured on ABC News, CNN and ESPN. He was one of the first specialists to be board-certified by the American Academy of Anti-Aging Medicine (A4M).
Dr. Feinerman offers stem cell treatments for a variety of disorders and diseases. He earned his medical degree from New York Medical College in 1954. Dr. Feinerman is affiliated with Long Island College Hospital in New York and Mayo Clinic in Rochester, Minnesota.
Dr. Feinerman is a member of the Society of Apheresis, Society of Bone Marrow Blood Transplantation, and the International Society for Cellular Therapy, the Society for Cranial Transplantation and Brain Repair and the Society for Cardiac Translational Therapy.
http://www.stemcellsgroup.com/advisory-board/
State-Of-The-Art Equipment
We’ll set you up with the best equipment you need to process stem cells and carry out the regenerative procedures for your patients..
http://stemcellslab.net/facility-and-equipment/
http://stemcellcenter.net/programs/
GLTA $LAHO GSCG
$LAHO..36 Stem Centers, 27 Countries..8k FILED..USDHHS conservative estimate $500 billion
Lans Holdings, Inc.
Our Email is:-investors@lansholdings.com
investors@lans.holdings
info@lansholdings.com
bizdev@lansholdings.com
For further information, please contact:
Telephone: +1.786.786.5758 and 305-755-7451
https://www.otcmarkets.com/stock/LAHO/disclosure
..(GSCG)..binding letter..to sell 100% to Lans Holdings Inc. (OTCPink: LAHO)
https://www.stemcellsgroup.com/lans-holdings-enters-into-binding-loi-to-acquire-global-stem-cells-group/
SEC filed.. penalty of $500,000 for the party that breaches terms of the binding LOI.
Lans Holdings Successfully Completes Due Diligence of Global Stem Cells Group
https://www.otcmarkets.com/stock/LAHO/news
$24.4M Zoominfo Prior Q
https://www.zoominfo.com/c/global-stem-cells-group-inc/357592775
AdiMarket $10M
1 of 27 Facilities, Stem Cells Group Chile $5.6M!
We’re positioning Adimarket to become the largest e-commerce marketplace for all things regenerative medicine,” says Benito Novas, founder and CEO of Global Stem Cells Group.
http://www.stemcellsgroup.com/adimarket-launches-website/
..Stem Cell Center, Inc. is the world's largest collective support & advisory network of regenerative medicine clinics and and physicians
http://stemcellcenter.net/
ADMIMARKET BIOTECHNOLOGY BIOMEDICAL EQUIPMENT CATALOGUE
https://2nvdue1pi3s51uaik42s7kgz-wpengine.netdna-ssl.com/wp-content/uploads/2017/05/ADIMarket_1.pdf
Advisory board!
http://adimarket.info/advisory-board/
https://stemcellsgroup.cl/scg/
http://stemcellcenter.net/
http://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=OfficerRegisteredAgentName&directionType=Initial&searchNameOrder=NOVASBENITO%20L120000749410&aggregateId=flal-l12000074941-c51a8233-2938-4f22-b6c7-c111a2e55ddc&searchTerm=Novasanos&listNameOrder=NOVASANOS%20F120000001373
https://www.marketwatch.com/press-release/global-stem-cell-therapy-market-insight-business-evaluation-dimension-industry-grow-at-cagr-of-3652-trends-and-forecasts-2018-2023-2019-03-06
..upsurge in venture capital investment represents growth of 7,300%
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
Regenerative medicine..USDHHS..conservatively estimated..$500 billion by 2020
Regenerative medicine will dramatically alter the U.S. healthcare industry
..Because of the economic potential of this industry (the worldwide market for regenerative medicine is conservatively estimated to be $500 billion..
An example of some conditions and diseases that could be easily cured by regenerative medicine and their current cost of treatmentt include:
250,000 patients receive heart valves, at a cost of $27 billion annually
950,000 people die of heart disease or stroke, at a cost of $351 billion annually(8)
17 million patients with diabetes, at a cost of $132 billion annually
..By doing so, we can make tissue and organ failure a relic of the past by 2020.
Interagency Federal Working Group on Regenerative Medicine
Chair
Howard Zucker, MD, JD
Deputy Assistant Secretary for Health
U.S. Department of Health and Human Services
National Institutes of Health
Donna Dean, PhD
Colleen Guay-Broder, MPH
Eleni Kousvelari, PhD
Christine Kelley, PhD
John Watson, PhD
Josh Zimmerberg, PhD
Food and Drug Administration
Charles Durfor, PhD
Donald Fink, PhD
Joyce Frey, PhD
Jesse Goodman, MD
Darin Weber, PhD
Celia Witten, PhD
http://singularity-2045.org/HHS-regenerative-medicine-2020-vision-archive-2014.html
Global Stem..Market to Reach US$ 467 billion by 2024 ..Due to the increased funding from Government and Private sector and rising global awareness.
https://www.marketwatch.com/press-release/global-stem-cells-market-is-determined-to-reach-us-467-billion-by-2024-2019-03-05
The Shiller P/E is a more reasonable market valuation indicator than the P/E ratio because it eliminates fluctuation of the ratio caused by the variation of profit margins during business cycles.
Sector Healthcare: 30.50
Sector Technology: 34.40
https://www.gurufocus.com/shiller-PE.php
http://www.econ.yale.edu/~shiller/
BioTechnology
https://www.nasdaq.com/press-release/laho-global-stem-cells-group-announces-opening-of-two-new-stem-cell-centers-20190612-00503
GSCG Attorney ERIC P. GROS-DUBOIS Flawless AVVO!
https://www.avvo.com/attorneys/33135-fl-eric-grosdubois-3340017.html
Eric P. Gros-Dubois, Esq.
Founding Partner
eric@epgdlaw.com
Executive Committee and Board Member of the Coral Gables Chamber of Commerce, former President of the Rotary Club of Brickell, current President of BNI Coral Gables, past president of his home owner’s association, and supporter of many fundraisers devoted to the community. Eric also regularly teaches other lawyers for their continuing legal education, presents to The American Immigration Lawyers Association, and more.
Washington College of Law. Juris Doctor (JD)
Kogod School of Business. Masters in Business Administration (MBA)
Southern Methodist University. Bachelor of Arts (BA). Sigma Chi Fraternity
Jesuit College Preparatory School, Dallas
Bar Admissions:
State of New York
State of Maryland
District of Columbia
State of Florida
Federal District Court for the Southern District of Florida
Federal District Court for Maryland
U.S. Tax Court
CLE Lecture: “The New Tax Rules for Mergers and Acquisitions.” June, 2018
https://www.epgdlaw.com/eric-p-gros-dubois/
https://www.floridabar.org/directories/find-mbr/profile/?num=83381
Scientists Are Developing New Ways to Treat Disease With Cells, Not Drugs
https://www.cancerresearch.org/blog/december-2018/james-allison-nobel-postdoc-fellow-perspectives
GSCG conference in Japan..
..After receiving a personal invitation from President Susumu Takayangi MD, Global Stem Cells Group and its Korean biotechnology partner, N-Biotek, participated in the 23rd Congress of the International Society of Aesthetic Plastic Surgeons that took place this October in Kyoto.
The Congress brought together an expert panel for a series of lectures and discussions that hope to provide solutions and create new techniques in the coming years to be applied in plastic and reconstructive surgery. Influential scientific and clinical experts stood together and evaluated the state of research and clinical application.
The keynote speaker in the conference was the Nobel Laureate Shinja Yamanaka. Dr Yamanaka won the award on 2012 for his creation of induced pluripotential stem cells. Yamanaka addressed among other things the importance of the regenerative medicine field opening a new frontier for the treatment of chronic degenerative conditions.
..Both companies, as leaders of the industry, launched their new Turnkey Solution, a compact and cohesive laboratory as a concept for physicians’ offices, and the new Progenikine Kit, an enzyme based closed system for isolation of adipose derived stem cells. To learn more, visit the Global Stem Cells Group website, www.stemcellsgroup.com.
https://www.stemcelltraining.net/global-stem-cells-group-participated-expositor-23rd-congress-isaps-2016-kyoto-japan/
https://time.com/5394912/stem-cell-treatment/?amp=true
Stem cells The Holy Grail Stansberry report!
..Doctors at St. Jude Children's Research Hospital used Mustang-developed "genetic surgery" to restore the broken immune systems of these eight infants afflicted with the disease. Stansberry Innovations Report editor Christian Olsen explained how this works in a private note on Friday...
First they extracted stem cells from a patient, then used a modified HIV virus to deliver and insert a healthy IL2RN gene into the stem cells, and then infused the modified stem cells back into the patient.
To get the patient ready to accept the changed cells, they were given a low dose of chemotherapy to prime the bone marrow. The bone marrow is what will produce blood cells from the genetically corrected stem cells and... Voila! Healthy immune system.
This may sound like science fiction. But it's not...
Gene therapy and editing is a real and growing trend you will hear about much more over the next several years. More from Christian...
This is real personalized medicine, which is the "Holy Grail." Cells were taken from a patient and used to create the treatment.
There is no doubt we are on the cusp of more of these success stories but, remember, at this stage we (at best) have a curative potential for "bubble boy" disease. There has to be more testing, but the news is incredibly promising.
So, MBIO shot up because it's the lead dog in this treatment tech, since it licensed it to treat patients at St. Jude.
https://stansberryresearch.com/articles/the-most-expensive-tech-stock-in-the-world-today-2
Oxford University
One of the greatest challenges of the 21st century is disease associated with ageing. Cancer, neurodegeneration and heart disease are all major causes of death and have an enormous impact on quality of life.
..Over recent years, a revolution in biology has meant that effective regenerative medicine, using stem cells to replace and repair damaged tissue is now on the horizon. Naturally occurring ‘immortal’ stem cells are present in all tissues of the body and act to replace loss of cells in tissues with rapid turnover, for example in the skin, blood or intestine, or to repair damage as in wound healing.
https://www.stemcells.ox.ac.uk/home
..Our human/mouse model demonstrated that proliferating hPSC-CPCs could reduce infract size and fibrosis resulting in formation of large grafts..
https://academic.oup.com/cardiovascres/advance-article/doi/10.1093/cvr/cvz181/5530198
..FDA says it’s unable to use the incomplete adverse event reporting data to quantify overall deaths that result from therapeutic drug use.
https://www.google.com/amp/s/health.usnews.com/health-news/patient-advice/articles/2016-09-27/the-danger-in-taking-prescribed-medications%3fcontext=amp
..“There has been an increased demand to develop effective drugs for cardiology and degenerative disorders, for which there were no effective treatment plans before the advent of stem therapies. The discovery of possible cardiac stem cells uncovered new arenas to repair hearts injured due to acute myocardial infarction or coronary artery disease,”
https://www.dailyprogress.com/opinion/opinion-commentary-global-stem-cell-therapy-market-to-showcase-growth/article_aeabbd8e-0106-11e7-a193-db25ffa753ac.amp.html
Harvard Stem Cell
..Our mission is to find cures for human diseases.
The Harvard community and the greater Boston area are home to the largest concentration of biomedical researchers in the world. This allows our network of over 1,000 scientists, from across Harvard and its eight affiliated hospitals, to advance stem cell biology and translational me
https://hsci.harvard.edu
Repairing the heart with stem cells
https://www.health.harvard.edu/heart-health/repairing-the-heart-with-stem-cells
Global Stem Cells Group and Adimarket to Represent Magellan in Latin America and Middle East.
https://www.prunderground.com/global-stem-cells-group-and-adimarket-to-represent-magellan-in-latin-america-and-middle-east/00112628/
Novas’ travel took him to Dubai, Oman and Kuwait where he met with investors and learned more about medical regulations in the region.
https://www.kuam.com/story/40113402/global-stem-cells-group-visits-middle-east-in-effort-to-expand-access-to-regenerative-medicine
Global Stem Cells Group has named Aesthetic Polyclinic in Abu Dhabi, UAE, exclusive representative for GSCG in that city.
https://www.prunderground.com/global-stem-cells-group-names-aesthetic-polyclinic-exclusive-representative-in-abu-dhabi/00109409/
Adimarket, has announced an agreement with biotechnology company Alolotl Biologix
..healing for a range of conditions, including orthopedic impairments, wound care, pain management, ophthalmic, cardiovascular, cosmetic, and more.
Human allograft under FDA regulation 21 CFR Part 1271 ..Immune privileged with anti-inflammatory and anti-bacterial properties
https://www.prunderground.com/adimarket-has-announced-an-agreement-with-biotechnology-company-alolotl-biologix/00114544/
Drug companies chase deals for cell and gene therapies, biotech's 'next wave'
..$20 billion in mergers and acquisitions in the cell and gene therapy space, or regenerative medicine, that year, according to the Alliance for Regenerative Medicine.
..FDA has "more than 800 active cell-based or directly administered gene therapy INDs on file."
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
..Stem Cell Banking Market to Witness Astonishing Growth
https://www.aglobalmarketresearch.com/stem-cell-banking-market-to-witness-astonishing-growth-of-10-cagr-by-2026-with-key-players-cord-blood-registry-cbr-systems-cordlife-group-limited-cryo-cell-international-viacord-cryo-save/
..Global Stem Cells Group Teams With CordónVida Servet Stem Cell Bank and Clinic to Organize the First International Symposium on Stem Cells and Regenerative Medicine
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.
Global Stem Cells Group, Inc. Announces Collaboration with VidaCel Laboratories and Stem Cell Bank, Chile..
http://stemcellcenter.net/global-stem-cells-group-inc-announces-collaboration-with-vidacel-laboratories-and-stem-cell-bank-chile/
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.htm
GSCG ISSCA Launch Dates.
•Santiago de Chile, Chile: September 5, 2019
•Bogota, Colombia: October 4, 2019
•Buenos Aires, Argentina: October 11, 2019
•Miami, Florida (in English): November 1, 2019
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149621212
..GSCG Knee Osteoarthrithis, Mayo Clinic Stem cell arthritis!
Mayo Clinic uses stem cell therapy to treat arthritis in knee
http://medprofvideos.mayoclinic.org/videos/mayo-clinic-uses-stem-cell-therapy-to-treat-arthritis-in-knee
Studies a U.S. FDA-regulated Device Product: YES
Estimated Study Start Date : May 13, 2019
Estimated Primary Completion Date : September 15, 2020
Estimated Study Completion Date : November 1, 2020
https://clinicaltrials.gov/ct2/show/NCT03752827
Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/
Nearly a decade of stem cell therapy experience
The cell is the minimal body’s representation, it is the basic unit for the living species where all the vital functions happen such as respiration, nutrition, and reproduction.
The STEM CELL is a special cell that normally circulates in the body, responsible for regenerating naturally the deteriorating organs. This treatment seeks for the stem cells to differentiate or become healthy cells from damaged or defective tissue to improve the function of the diseased organ.
http://cellgenic.com/
Exosomes are currently non-reactive and FDA approved.
ADIMARKET..Flow uses exosomes in compliance with US regulations to provide innovative treatment options to those suffering from degenerative diseases.
..Exosomes provide an exciting new treatment option for those suffering from degenerative diseases.
https://www.abc-7.com/story/40368805/adimarket-releases-new-exosomes-product-that-delivers-therapeutic-promise
LAHO!..CEO Announces..New Stem Cell Center in Valencia, Spain
..“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1376239
....“Our objective is to bring this cutting-edge3D bioprinting technology to scientists and regenerative medicine researcher..
https://www.facebook.com/pg/globalstemcells/photos/?ref=page_internal
LAHO CEO Dave Christensen highly skilled.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149320841
..ISSCA Set to Host Regenerative Medicine Symposium in Buenos Aires
https://www.stemcellsgroup.com/
Adimarket featured products!
Magellan PRP The Magellan® technology
32” Portable Clean Room $4,500.00
INKREDIBLE 3D BIOPRINTER
BEAR C2202 Centrifuge $3,000.00
Shockwave Machine $3,500.00
H.I.F.U High Intensity Focused Ultrasound $7,500.00
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149417821
https://www.adimarket.net/product-category/in-office-processing-equipment/
Global Stem Cells Group CEO Benito Novas is driven by his passion for helping physicians and scientists change the world through stem cell medicine. Dedicated to creating critical organizational systems that ensure success, he is an expert in the field of specialized marketing focused on Biotechnology, Life Sciences, and Healthcare development.
http://www.stemcellsgroup.com/management/
Global Stem Cells Group’s Benito Novas Announces Agreement with Clinica Planas
..The ongoing partnership will offer certification in regenerative medicine for European-based medical practitioners .
https://www.stemcellsgroup.com/benito-novas-announces-agreement-with-clinica-
https://cursocelulasmadre.com/entrenamiento-en-
GSCG is #1 Competitor for Biostems Tech $1.52
Dark Defunct
GCSG is #1 competitor for Beike Biotechnology.
GSCG is #1 competitor of Global Institute Of Stem Cell Therapy And Research!
..Stem cells are jacks of all trades, capable of alleviating the consequences of such diverse pathologies as heart attacks, strokes and cancer.
..In a new study, Yale researchers succeeded in doing so, opening the door to new stem cell-inspired, cell-free treatments for the effects of a heart attack.
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
“Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth,” says the US National Institutes of Health. “In many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive
Market cap: $2.09 billion; current share price: $24.25
Market cap: $226.15 Million; current share price: $1.83
Market cap: $161.84 million; current share price: $1.47
Market cap: $267.60 million; current share price: $19.10
Market cap: $392.71 million; current share price: $11.25
Market cap: $64.63 million; current share price: $3.43
Market cap: $54.74 million; current share price: $5.78
Market cap: $11.05 million; current share price: $0.31
Market cap: $29.88 million; current share price: $2.75
Market cap: $28.40 million; current share price: $1.30
https://investingnews.com/daily/life-science-investing/genetics-investing/top-stem-cell-nasdaq/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149422974
http://www.stemcellsgroup.com/adimarket-launches-website/
..Bioheart, Inc. (otcqb:BHRT), a biotech company focused on the discovery, development and commercialization of autologous cell therapies, has announced that it has initiated a new clinical site in collaboration with Global Stem Cell Group in Cozumel, Mexico. The two companies have successfully treated their first congestive heart failure patient at the new clinical site last week using Bioheart's AdipoCell (adipose derived stem cells).
https://www.marketwatch.com/press-release/bioheart-announces-new-clinical-site-in-mexico-2013-11-25
Advancells ties up with Global Stem Cells Group
https://ehealth.eletsonline.com/2015/03/advancells-ties-global-stem-cells-group/amp/
Global Stem Cells Group and Kimera Labs Announce Autologous Stem Cell Research Alliance
https://www.streetinsider.com/dr/news.php?id=11539116
Global Stem Cells Group's Chile Facility Expected to Receive Regenetech RTA Certification
https://www.newswire.com/news/global-stem-cells-groups-chile-facility-expected-to-receive-regenetech-rta
Global Stem Cells Group to Host Stem Cells and Regenerative ...
ISSCA Physicians looking for new alternatives to improve the quality of life of their patients through emerging regenerative medicine protocols..
https://www.issca.us/stem-cells-and-regenerative-medicine-conference-in-miami/
“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
In opening the new center, the GSCG has signed an agreement with Dra. Laura Maria Caicedo, medical director of the Instituto Valenciano MEDEC (https://medec.es/conoce-medec/#equipoMedico). Dr. Caicedo is a specialist on hair loss with an interest in delivering stem cell based treatments to her patients and others in Valencia.
https://medec.es/conoce-medec/#equipoMedico
http://www.stemcellsgroup.com
Barcelona, Spain
J. Victor Garcia Gimenez, M.D. is president of Therapeutic Confrontations (CONFTERA), is a specialist in orthopedic surgery and practices cosmetic medicine and surgery, anti-aging medicine, and aesthetic therapies in Barcelona, Spain.
http://stemcellcenter.net/centers/spain/barcelona/barcelona-spain/\
GSCG..ISSCA Reaches Agreement with Belgium’s Churchill Aesthetic Center
..The International Society for Stem Cell Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and...
Friday, June 21st 2019, 12:32 PM CDT
The innovative new center will provide training in regenerative medicine for doctors located in Belgium and France.
..We look forward to ISSCA’s exciting new partnership with Belgium’s Churchill Aesthetic Center and the possibilities it brings in delivering safe and effective regenerative medicine treatment options to more patients across the globe,” said Benito Novas, CEO of the Global Stem Cells Group.
https://www.newschannelnebraska.com/story/40691664/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center
https://www.churchill-aesthetic-center.be/autres-specialites/
....The cutting-edge facility will be equipped by Adimarket, LLC, a subsidiary of the Global Stem Cells Group. Adimarket will outfit the center with equipment and supplies designed to not only teach doctors about the latest protocols in regenerative medicine but also to treat patients suffering from degenerative diseases and sports injuries. Physicians training at the facility will have access to the proven expertise of ISSCA’s global network and training protocols.
http://www.stemcellsgroup.com/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center/
Daeyong Kim, Ph.D. is an internationally recognized health educator, and CEO of N-Biotek, Inc, a preeminent manufacturer of biomedical and laboratory equipment. N-Biotek is a leader of stem cell technologies, providing solutions for providers worldwide.
..Dr. Zhang is an accomplished scientist, microbiologist and virologist who has worked extensively in the U.S. for the CDC, the National Institutes of Health (NIH) and the US Food and Drug Administration in various research positions, including senior associate at the National Research Center. A Chinese-American, Dr. Zhang received the Award for Scientific Achievement from the FDA
..Al Sears, M.D. often referred to as "America’s #1 anti-aging doctor," is the director of the world renowned Sears Institute for Anti-aging Medicine. Dr. Sears has published 35 books and reports on health and wellness, and has millions of loyal readers in 163 countries. Dr. Sears has been featured on ABC News, CNN and ESPN. He was one of the first specialists to be board-certified by the American Academy of Anti-Aging Medicine (A4M).
Dr. Feinerman offers stem cell treatments for a variety of disorders and diseases. He earned his medical degree from New York Medical College in 1954. Dr. Feinerman is affiliated with Long Island College Hospital in New York and Mayo Clinic in Rochester, Minnesota.
Dr. Feinerman is a member of the Society of Apheresis, Society of Bone Marrow Blood Transplantation, and the International Society for Cellular Therapy, the Society for Cranial Transplantation and Brain Repair and the Society for Cardiac Translational Therapy.
http://www.stemcellsgroup.com/advisory-board/
State-Of-The-Art Equipment
We’ll set you up with the best equipment you need to process stem cells and carry out the regenerative procedures for your patients..
http://stemcellslab.net/facility-and-equipment/
http://stemcellcenter.net/programs/
GLTA $LAHO GSCG
$LAHO WALLSTREET #1 most active MORNINGSTAR.
http://finra-markets.morningstar.com/MarketData/EquityOptions/default.jsp
$LAHO MONSTER WAVE COMING.
$LAHO..has engaged Fruci & Associates as its auditors as it moves forward to complete its audits and reviews of its financials to bring the company back to current status.
https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1404069
417M BUYS 283 SELLS
https://ih.advfn.com/stock-market/USOTC/lans-holdings-inc-LAHO/trades
$LAHO Lans Holdings Successfully Completes Due Diligence of Global Stem Cells Group. ALL IN ORDER, DUE TIME!
$LAHO..Stem Cells..USDHHS conservative estimate $500 billion
Lans Holdings, Inc.
Our Email is:-investors@lansholdings.com
investors@lans.holdings
info@lansholdings.com
bizdev@lansholdings.com
For further information, please contact:
Telephone: +1.786.786.5758 and 305-755-7451
https://www.otcmarkets.com/stock/LAHO/disclosure
..(GSCG)..binding letter..to sell 100% to Lans Holdings Inc. (OTCPink: LAHO)
https://www.stemcellsgroup.com/lans-holdings-enters-into-binding-loi-to-acquire-global-stem-cells-group/
SEC filed.. penalty of $500,000 for the party that breaches terms of the binding LOI.
Lans Holdings Successfully Completes Due Diligence of Global Stem Cells Group
https://www.otcmarkets.com/stock/LAHO/news
$24.4M Zoominfo Prior Q
https://www.zoominfo.com/c/global-stem-cells-group-inc/357592775
AdiMarket $10M
1 of 27 Facilities, Stem Cells Group Chile $5.6M!
We’re positioning Adimarket to become the largest e-commerce marketplace for all things regenerative medicine,” says Benito Novas, founder and CEO of Global Stem Cells Group.
http://www.stemcellsgroup.com/adimarket-launches-website/
..Stem Cell Center, Inc. is the world's largest collective support & advisory network of regenerative medicine clinics and and physicians
http://stemcellcenter.net/
ADMIMARKET BIOTECHNOLOGY BIOMEDICAL EQUIPMENT CATALOGUE
https://2nvdue1pi3s51uaik42s7kgz-wpengine.netdna-ssl.com/wp-content/uploads/2017/05/ADIMarket_1.pdf
Advisory board!
http://adimarket.info/advisory-board/
https://stemcellsgroup.cl/scg/
http://stemcellcenter.net/
http://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=OfficerRegisteredAgentName&directionType=Initial&searchNameOrder=NOVASBENITO%20L120000749410&aggregateId=flal-l12000074941-c51a8233-2938-4f22-b6c7-c111a2e55ddc&searchTerm=Novasanos&listNameOrder=NOVASANOS%20F120000001373
https://www.marketwatch.com/press-release/global-stem-cell-therapy-market-insight-business-evaluation-dimension-industry-grow-at-cagr-of-3652-trends-and-forecasts-2018-2023-2019-03-06
..upsurge in venture capital investment represents growth of 7,300%
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
Regenerative medicine..USDHHS..conservatively estimated..$500 billion by 2020
Regenerative medicine will dramatically alter the U.S. healthcare industry
..Because of the economic potential of this industry (the worldwide market for regenerative medicine is conservatively estimated to be $500 billion..
An example of some conditions and diseases that could be easily cured by regenerative medicine and their current cost of treatmentt include:
250,000 patients receive heart valves, at a cost of $27 billion annually
950,000 people die of heart disease or stroke, at a cost of $351 billion annually(8)
17 million patients with diabetes, at a cost of $132 billion annually
..By doing so, we can make tissue and organ failure a relic of the past by 2020.
Interagency Federal Working Group on Regenerative Medicine
Chair
Howard Zucker, MD, JD
Deputy Assistant Secretary for Health
U.S. Department of Health and Human Services
National Institutes of Health
Donna Dean, PhD
Colleen Guay-Broder, MPH
Eleni Kousvelari, PhD
Christine Kelley, PhD
John Watson, PhD
Josh Zimmerberg, PhD
Food and Drug Administration
Charles Durfor, PhD
Donald Fink, PhD
Joyce Frey, PhD
Jesse Goodman, MD
Darin Weber, PhD
Celia Witten, PhD
http://singularity-2045.org/HHS-regenerative-medicine-2020-vision-archive-2014.html
Global Stem..Market to Reach US$ 467 billion by 2024 ..Due to the increased funding from Government and Private sector and rising global awareness.
https://www.marketwatch.com/press-release/global-stem-cells-market-is-determined-to-reach-us-467-billion-by-2024-2019-03-05
The Shiller P/E is a more reasonable market valuation indicator than the P/E ratio because it eliminates fluctuation of the ratio caused by the variation of profit margins during business cycles.
Sector Healthcare: 30.50
Sector Technology: 34.40
https://www.gurufocus.com/shiller-PE.php
http://www.econ.yale.edu/~shiller/
BioTechnology
https://www.nasdaq.com/press-release/laho-global-stem-cells-group-announces-opening-of-two-new-stem-cell-centers-20190612-00503
GSCG Attorney ERIC P. GROS-DUBOIS Flawless AVVO!
https://www.avvo.com/attorneys/33135-fl-eric-grosdubois-3340017.html
Eric P. Gros-Dubois, Esq.
Founding Partner
eric@epgdlaw.com
Executive Committee and Board Member of the Coral Gables Chamber of Commerce, former President of the Rotary Club of Brickell, current President of BNI Coral Gables, past president of his home owner’s association, and supporter of many fundraisers devoted to the community. Eric also regularly teaches other lawyers for their continuing legal education, presents to The American Immigration Lawyers Association, and more.
Washington College of Law. Juris Doctor (JD)
Kogod School of Business. Masters in Business Administration (MBA)
Southern Methodist University. Bachelor of Arts (BA). Sigma Chi Fraternity
Jesuit College Preparatory School, Dallas
Bar Admissions:
State of New York
State of Maryland
District of Columbia
State of Florida
Federal District Court for the Southern District of Florida
Federal District Court for Maryland
U.S. Tax Court
CLE Lecture: “The New Tax Rules for Mergers and Acquisitions.” June, 2018
https://www.epgdlaw.com/eric-p-gros-dubois/
https://www.floridabar.org/directories/find-mbr/profile/?num=83381
Scientists Are Developing New Ways to Treat Disease With Cells, Not Drugs
https://www.cancerresearch.org/blog/december-2018/james-allison-nobel-postdoc-fellow-perspectives
GSCG conference in Japan..
..After receiving a personal invitation from President Susumu Takayangi MD, Global Stem Cells Group and its Korean biotechnology partner, N-Biotek, participated in the 23rd Congress of the International Society of Aesthetic Plastic Surgeons that took place this October in Kyoto.
The Congress brought together an expert panel for a series of lectures and discussions that hope to provide solutions and create new techniques in the coming years to be applied in plastic and reconstructive surgery. Influential scientific and clinical experts stood together and evaluated the state of research and clinical application.
The keynote speaker in the conference was the Nobel Laureate Shinja Yamanaka. Dr Yamanaka won the award on 2012 for his creation of induced pluripotential stem cells. Yamanaka addressed among other things the importance of the regenerative medicine field opening a new frontier for the treatment of chronic degenerative conditions.
..Both companies, as leaders of the industry, launched their new Turnkey Solution, a compact and cohesive laboratory as a concept for physicians’ offices, and the new Progenikine Kit, an enzyme based closed system for isolation of adipose derived stem cells. To learn more, visit the Global Stem Cells Group website, www.stemcellsgroup.com.
https://www.stemcelltraining.net/global-stem-cells-group-participated-expositor-23rd-congress-isaps-2016-kyoto-japan/
https://time.com/5394912/stem-cell-treatment/?amp=true
Stem cells The Holy Grail Stansberry report!
..Doctors at St. Jude Children's Research Hospital used Mustang-developed "genetic surgery" to restore the broken immune systems of these eight infants afflicted with the disease. Stansberry Innovations Report editor Christian Olsen explained how this works in a private note on Friday...
First they extracted stem cells from a patient, then used a modified HIV virus to deliver and insert a healthy IL2RN gene into the stem cells, and then infused the modified stem cells back into the patient.
To get the patient ready to accept the changed cells, they were given a low dose of chemotherapy to prime the bone marrow. The bone marrow is what will produce blood cells from the genetically corrected stem cells and... Voila! Healthy immune system.
This may sound like science fiction. But it's not...
Gene therapy and editing is a real and growing trend you will hear about much more over the next several years. More from Christian...
This is real personalized medicine, which is the "Holy Grail." Cells were taken from a patient and used to create the treatment.
There is no doubt we are on the cusp of more of these success stories but, remember, at this stage we (at best) have a curative potential for "bubble boy" disease. There has to be more testing, but the news is incredibly promising.
So, MBIO shot up because it's the lead dog in this treatment tech, since it licensed it to treat patients at St. Jude.
https://stansberryresearch.com/articles/the-most-expensive-tech-stock-in-the-world-today-2
Oxford University
One of the greatest challenges of the 21st century is disease associated with ageing. Cancer, neurodegeneration and heart disease are all major causes of death and have an enormous impact on quality of life.
..Over recent years, a revolution in biology has meant that effective regenerative medicine, using stem cells to replace and repair damaged tissue is now on the horizon. Naturally occurring ‘immortal’ stem cells are present in all tissues of the body and act to replace loss of cells in tissues with rapid turnover, for example in the skin, blood or intestine, or to repair damage as in wound healing.
https://www.stemcells.ox.ac.uk/home
..Our human/mouse model demonstrated that proliferating hPSC-CPCs could reduce infract size and fibrosis resulting in formation of large grafts..
https://academic.oup.com/cardiovascres/advance-article/doi/10.1093/cvr/cvz181/5530198
..FDA says it’s unable to use the incomplete adverse event reporting data to quantify overall deaths that result from therapeutic drug use.
https://www.google.com/amp/s/health.usnews.com/health-news/patient-advice/articles/2016-09-27/the-danger-in-taking-prescribed-medications%3fcontext=amp
..“There has been an increased demand to develop effective drugs for cardiology and degenerative disorders, for which there were no effective treatment plans before the advent of stem therapies. The discovery of possible cardiac stem cells uncovered new arenas to repair hearts injured due to acute myocardial infarction or coronary artery disease,”
https://www.dailyprogress.com/opinion/opinion-commentary-global-stem-cell-therapy-market-to-showcase-growth/article_aeabbd8e-0106-11e7-a193-db25ffa753ac.amp.html
Harvard Stem Cell
..Our mission is to find cures for human diseases.
The Harvard community and the greater Boston area are home to the largest concentration of biomedical researchers in the world. This allows our network of over 1,000 scientists, from across Harvard and its eight affiliated hospitals, to advance stem cell biology and translational me
https://hsci.harvard.edu
Repairing the heart with stem cells
https://www.health.harvard.edu/heart-health/repairing-the-heart-with-stem-cells
Global Stem Cells Group and Adimarket to Represent Magellan in Latin America and Middle East.
https://www.prunderground.com/global-stem-cells-group-and-adimarket-to-represent-magellan-in-latin-america-and-middle-east/00112628/
Novas’ travel took him to Dubai, Oman and Kuwait where he met with investors and learned more about medical regulations in the region.
https://www.kuam.com/story/40113402/global-stem-cells-group-visits-middle-east-in-effort-to-expand-access-to-regenerative-medicine
Global Stem Cells Group has named Aesthetic Polyclinic in Abu Dhabi, UAE, exclusive representative for GSCG in that city.
https://www.prunderground.com/global-stem-cells-group-names-aesthetic-polyclinic-exclusive-representative-in-abu-dhabi/00109409/
Adimarket, has announced an agreement with biotechnology company Alolotl Biologix
..healing for a range of conditions, including orthopedic impairments, wound care, pain management, ophthalmic, cardiovascular, cosmetic, and more.
Human allograft under FDA regulation 21 CFR Part 1271 ..Immune privileged with anti-inflammatory and anti-bacterial properties
https://www.prunderground.com/adimarket-has-announced-an-agreement-with-biotechnology-company-alolotl-biologix/00114544/
Drug companies chase deals for cell and gene therapies, biotech's 'next wave'
..$20 billion in mergers and acquisitions in the cell and gene therapy space, or regenerative medicine, that year, according to the Alliance for Regenerative Medicine.
..FDA has "more than 800 active cell-based or directly administered gene therapy INDs on file."
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
..Stem Cell Banking Market to Witness Astonishing Growth
https://www.aglobalmarketresearch.com/stem-cell-banking-market-to-witness-astonishing-growth-of-10-cagr-by-2026-with-key-players-cord-blood-registry-cbr-systems-cordlife-group-limited-cryo-cell-international-viacord-cryo-save/
..Global Stem Cells Group Teams With CordónVida Servet Stem Cell Bank and Clinic to Organize the First International Symposium on Stem Cells and Regenerative Medicine
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.
Global Stem Cells Group, Inc. Announces Collaboration with VidaCel Laboratories and Stem Cell Bank, Chile..
http://stemcellcenter.net/global-stem-cells-group-inc-announces-collaboration-with-vidacel-laboratories-and-stem-cell-bank-chile/
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.htm
GSCG ISSCA Launch Dates.
•Santiago de Chile, Chile: September 5, 2019
•Bogota, Colombia: October 4, 2019
•Buenos Aires, Argentina: October 11, 2019
•Miami, Florida (in English): November 1, 2019
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149621212
..GSCG Knee Osteoarthrithis, Mayo Clinic Stem cell arthritis!
Mayo Clinic uses stem cell therapy to treat arthritis in knee
http://medprofvideos.mayoclinic.org/videos/mayo-clinic-uses-stem-cell-therapy-to-treat-arthritis-in-knee
Studies a U.S. FDA-regulated Device Product: YES
Estimated Study Start Date : May 13, 2019
Estimated Primary Completion Date : September 15, 2020
Estimated Study Completion Date : November 1, 2020
https://clinicaltrials.gov/ct2/show/NCT03752827
Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/
Nearly a decade of stem cell therapy experience
The cell is the minimal body’s representation, it is the basic unit for the living species where all the vital functions happen such as respiration, nutrition, and reproduction.
The STEM CELL is a special cell that normally circulates in the body, responsible for regenerating naturally the deteriorating organs. This treatment seeks for the stem cells to differentiate or become healthy cells from damaged or defective tissue to improve the function of the diseased organ.
http://cellgenic.com/
Exosomes are currently non-reactive and FDA approved.
ADIMARKET..Flow uses exosomes in compliance with US regulations to provide innovative treatment options to those suffering from degenerative diseases.
..Exosomes provide an exciting new treatment option for those suffering from degenerative diseases.
https://www.abc-7.com/story/40368805/adimarket-releases-new-exosomes-product-that-delivers-therapeutic-promise
LAHO!..CEO Announces..New Stem Cell Center in Valencia, Spain
..“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1376239
....“Our objective is to bring this cutting-edge3D bioprinting technology to scientists and regenerative medicine researcher..
https://www.facebook.com/pg/globalstemcells/photos/?ref=page_internal
LAHO CEO Dave Christensen highly skilled.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149320841
..ISSCA Set to Host Regenerative Medicine Symposium in Buenos Aires
https://www.stemcellsgroup.com/
Adimarket featured products!
Magellan PRP The Magellan® technology
32” Portable Clean Room $4,500.00
INKREDIBLE 3D BIOPRINTER
BEAR C2202 Centrifuge $3,000.00
Shockwave Machine $3,500.00
H.I.F.U High Intensity Focused Ultrasound $7,500.00
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149417821
https://www.adimarket.net/product-category/in-office-processing-equipment/
Global Stem Cells Group CEO Benito Novas is driven by his passion for helping physicians and scientists change the world through stem cell medicine. Dedicated to creating critical organizational systems that ensure success, he is an expert in the field of specialized marketing focused on Biotechnology, Life Sciences, and Healthcare development.
http://www.stemcellsgroup.com/management/
Global Stem Cells Group’s Benito Novas Announces Agreement with Clinica Planas
..The ongoing partnership will offer certification in regenerative medicine for European-based medical practitioners .
https://www.stemcellsgroup.com/benito-novas-announces-agreement-with-clinica-
https://cursocelulasmadre.com/entrenamiento-en-
GSCG is #1 Competitor for Biostems Tech $1.52
Dark Defunct
GCSG is #1 competitor for Beike Biotechnology.
GSCG is #1 competitor of Global Institute Of Stem Cell Therapy And Research!
..Stem cells are jacks of all trades, capable of alleviating the consequences of such diverse pathologies as heart attacks, strokes and cancer.
..In a new study, Yale researchers succeeded in doing so, opening the door to new stem cell-inspired, cell-free treatments for the effects of a heart attack.
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
“Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth,” says the US National Institutes of Health. “In many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive
Market cap: $2.09 billion; current share price: $24.25
Market cap: $226.15 Million; current share price: $1.83
Market cap: $161.84 million; current share price: $1.47
Market cap: $267.60 million; current share price: $19.10
Market cap: $392.71 million; current share price: $11.25
Market cap: $64.63 million; current share price: $3.43
Market cap: $54.74 million; current share price: $5.78
Market cap: $11.05 million; current share price: $0.31
Market cap: $29.88 million; current share price: $2.75
Market cap: $28.40 million; current share price: $1.30
https://investingnews.com/daily/life-science-investing/genetics-investing/top-stem-cell-nasdaq/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149422974
http://www.stemcellsgroup.com/adimarket-launches-website/
..Bioheart, Inc. (otcqb:BHRT), a biotech company focused on the discovery, development and commercialization of autologous cell therapies, has announced that it has initiated a new clinical site in collaboration with Global Stem Cell Group in Cozumel, Mexico. The two companies have successfully treated their first congestive heart failure patient at the new clinical site last week using Bioheart's AdipoCell (adipose derived stem cells).
https://www.marketwatch.com/press-release/bioheart-announces-new-clinical-site-in-mexico-2013-11-25
Advancells ties up with Global Stem Cells Group
https://ehealth.eletsonline.com/2015/03/advancells-ties-global-stem-cells-group/amp/
Global Stem Cells Group and Kimera Labs Announce Autologous Stem Cell Research Alliance
https://www.streetinsider.com/dr/news.php?id=11539116
Global Stem Cells Group's Chile Facility Expected to Receive Regenetech RTA Certification
https://www.newswire.com/news/global-stem-cells-groups-chile-facility-expected-to-receive-regenetech-rta
Global Stem Cells Group to Host Stem Cells and Regenerative ...
ISSCA Physicians looking for new alternatives to improve the quality of life of their patients through emerging regenerative medicine protocols..
https://www.issca.us/stem-cells-and-regenerative-medicine-conference-in-miami/
“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
In opening the new center, the GSCG has signed an agreement with Dra. Laura Maria Caicedo, medical director of the Instituto Valenciano MEDEC (https://medec.es/conoce-medec/#equipoMedico). Dr. Caicedo is a specialist on hair loss with an interest in delivering stem cell based treatments to her patients and others in Valencia.
https://medec.es/conoce-medec/#equipoMedico
http://www.stemcellsgroup.com
Barcelona, Spain
J. Victor Garcia Gimenez, M.D. is president of Therapeutic Confrontations (CONFTERA), is a specialist in orthopedic surgery and practices cosmetic medicine and surgery, anti-aging medicine, and aesthetic therapies in Barcelona, Spain.
http://stemcellcenter.net/centers/spain/barcelona/barcelona-spain/\
GSCG..ISSCA Reaches Agreement with Belgium’s Churchill Aesthetic Center
..The International Society for Stem Cell Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and...
Friday, June 21st 2019, 12:32 PM CDT
The innovative new center will provide training in regenerative medicine for doctors located in Belgium and France.
..We look forward to ISSCA’s exciting new partnership with Belgium’s Churchill Aesthetic Center and the possibilities it brings in delivering safe and effective regenerative medicine treatment options to more patients across the globe,” said Benito Novas, CEO of the Global Stem Cells Group.
https://www.newschannelnebraska.com/story/40691664/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center
https://www.churchill-aesthetic-center.be/autres-specialites/
....The cutting-edge facility will be equipped by Adimarket, LLC, a subsidiary of the Global Stem Cells Group. Adimarket will outfit the center with equipment and supplies designed to not only teach doctors about the latest protocols in regenerative medicine but also to treat patients suffering from degenerative diseases and sports injuries. Physicians training at the facility will have access to the proven expertise of ISSCA’s global network and training protocols.
http://www.stemcellsgroup.com/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center/
Daeyong Kim, Ph.D. is an internationally recognized health educator, and CEO of N-Biotek, Inc, a preeminent manufacturer of biomedical and laboratory equipment. N-Biotek is a leader of stem cell technologies, providing solutions for providers worldwide.
..Dr. Zhang is an accomplished scientist, microbiologist and virologist who has worked extensively in the U.S. for the CDC, the National Institutes of Health (NIH) and the US Food and Drug Administration in various research positions, including senior associate at the National Research Center. A Chinese-American, Dr. Zhang received the Award for Scientific Achievement from the FDA
..Al Sears, M.D. often referred to as "America’s #1 anti-aging doctor," is the director of the world renowned Sears Institute for Anti-aging Medicine. Dr. Sears has published 35 books and reports on health and wellness, and has millions of loyal readers in 163 countries. Dr. Sears has been featured on ABC News, CNN and ESPN. He was one of the first specialists to be board-certified by the American Academy of Anti-Aging Medicine (A4M).
Dr. Feinerman offers stem cell treatments for a variety of disorders and diseases. He earned his medical degree from New York Medical College in 1954. Dr. Feinerman is affiliated with Long Island College Hospital in New York and Mayo Clinic in Rochester, Minnesota.
Dr. Feinerman is a member of the Society of Apheresis, Society of Bone Marrow Blood Transplantation, and the International Society for Cellular Therapy, the Society for Cranial Transplantation and Brain Repair and the Society for Cardiac Translational Therapy.
http://www.stemcellsgroup.com/advisory-board/
State-Of-The-Art Equipment
We’ll set you up with the best equipment you need to process stem cells and carry out the regenerative procedures for your patients..
http://stemcellslab.net/facility-and-equipment/
http://stemcellcenter.net/programs/
GLTA $LAHO GSCG
$LAHO SEC FILED..fiscal years..2016..2015 contained no adverse opinion or disclaimer of opinion,
https://www.sec.gov/Archives/edgar/data/1422059/000166357719000317/mainbody.htm
$LAHO pennies will come in a blink!!